Form 6-K CHINA LIFE INSURANCE CO For: Mar 23
Commission File Number 001-31914
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 6-K
Report of Foreign Private Issuer
Pursuant to Rule 13a-16 or 15d-16 of the
Securities Exchange Act of 1934
March 23, 2016
China Life Insurance Company Limited
(Translation of registrants name into English)
16 Financial Street
Xicheng District
Beijing 100033, China
Tel: (86-10) 6363-3333
(Address of principal executive offices)
Indicate by check mark whether the registrant files or will file annual reports under cover Form 20-F or Form 40-F:
Form 20-F x Form 40-F ¨
Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1): ¨
Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7): ¨
Indicate by check mark whether by furnishing the information contained in this Form, the registrant is also thereby furnishing the information to the Commission pursuant to Rule 12g3-2(b) under the Securities Exchange Act of 1934:
Yes ¨ No x
If Yes is marked, indicate below the file number assigned to the registrant in connection with Rule 12g3-2(b): 82-
Commission File Number 001-31914
On March 23, 2016, China Life Insurance Company Limited issued an Announcement of Results for the year ended December 31, 2015, a copy of which is attached as Exhibit 99.1 hereto.
Certain statements contained in this press release may be viewed as forward-looking statements within the meaning of Section 27A of the U.S. Securities Act of 1933, as amended, and Section 21E of the U.S. Securities Exchange Act of 1934, as amended. Such forward-looking statements involve known and unknown risks, uncertainties and other factors, which may cause the actual performance, financial condition or results of operations of the Company to be materially different from any future performance, financial condition or results of operations implied by such forward-looking statements. Further information regarding these risks, uncertainties and other factors is included in the Companys Annual Report on Form 20-F for the fiscal year ended December 31, 2014 filed with the U.S. Securities and Exchange Commission, or SEC, on April 24, 2015 and in the Companys other filings with the SEC. You should not place undue reliance on these forward-looking statements. All information provided in this press release is as of the date of this press release, unless otherwise stated, and we undertake no duty to update such information, except as required under applicable law. Unless otherwise indicated, the Chinese insurance market information set forth in this press release is based on public information released by the China Insurance Regulatory Commission.
EXHIBIT LIST
Exhibit | Description | |
99.1 | Announcement, dated March 23, 2016 |
Commission File Number 001-31914
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
China Life Insurance Company Limited | ||||
(Registrant) | ||||
By: | /s/ Lin Dairen | |||
(Signature) | ||||
March 23, 2016 | Name: Title: |
Lin Dairen President and Executive Director |
Exhibit 99.1
CHINA LIFE INSURANCE COMPANY LIMITED
(A joint stock limited company incorporated in the Peoples Republic of China with limited liability)
(Stock Code: 2628)
ANNOUNCEMENT OF RESULTS FOR THE YEAR ENDED 31 DECEMBER 2015
CHAIRMANS STATEMENT
In 2015, faced with the complicated international environment and the challenging tasks of carrying out reform and development and maintaining stability at home, China experienced stable economic development as a whole together with progress being achieved and stability ensured, which provided a favorable environment for the sound and fast development of insurance industry. In this year, the Company proactively adapted to the new normal state of economic development by firmly adhering to the operation ideas of emphasizing value, strengthening sales force, optimizing structure and achieving stable growth, implementing the innovation-driven development strategy in great depth, capturing opportunities, responding calmly and confidently, staying realistic and pragmatic and forging ahead with determination, and thus achieved the best operation results since the 12th Five-Year Plan. The Company achieved new heights in its business development, with the growth rate of first-year regular premiums achieving a new high record since the share restructuring and listing of the Company, and the growth rates of both gross written premiums and first-year regular premiums with 10 years or longer payment duration being the highest over the past seven years. The Companys efficiency was continuously improved due to structure optimization, with the one-year new business value hitting a record high. The Companys sales force reached a new high level with its number surpassing one million for the first time in the Companys history. The Companys development achieved the balance between speed and efficiency, size and structure, and short-term and long-term operation, bringing a successful close to the Companys 12th Five-Year Plan.
1
During the Reporting Period, the Companys total revenue was RMB507,449 million, a 15.1% increase year-on-year; net profit attributable to equity holders of the Company was RMB34,699 million, a 7.7% increase year-on-year; earnings per share (basic and diluted) were RMB1.22, a 7.1% increase year-on-year. One-year new business value was RMB31,528 million, a 35.6% increase year-on-year. The Companys market share1 in 2015 was approximately 23.0%, maintaining a leading position in the life insurance market. As at the end of the Reporting Period, the Companys total assets reached RMB2,448,315 million, an increase of 9.0% from the end of 2014; embedded value was RMB560,277 million, an increase of 23.2% from 2014. As at 31 December 2015, the Companys solvency ratio was 330.10%.
The Board of Directors of the Company proposes the payment of a final dividend of RMB0.42 per share (inclusive of tax), subject to the shareholders approval at the 2015 Annual General Meeting to be held on Monday, 30 May 2016.
The Company has continually improved its corporate governance. During the Reporting Period, the Company successfully completed the change of sessions of the Board of Directors and the Supervisory Committee and elected the fifth sessions of the Board of Directors and the Supervisory Committee. Mr. Xu Hengping, Mr. Xu Haifeng, Mr. Liu Jiade, Mr. Robinson Drake Pike and Mr. Tang Xin joined the new session of the Board of Directors, and Mr. Miao Ping, Mr. Zhan Zhong and Ms. Wang Cuifei joined the new session of the Supervisory Committee. The new sessions of the Board of Directors and the Supervisory Committee continue to play roles of decision-making and supervision in a variety of areas, such as strategic planning, risk management, internal control and compliance, and performance appraisal, etc. Meanwhile, the Company would like to express its gratitude to the resigned/retired Directors, Mr. Su Hengxuan, Mr. Miao Ping, Mr. Bruce Douglas Moore and Mr. Huang Yiping, and the retired Supervisors, Ms. Xia Zhihua, Ms. Yang Cuilian and Mr. Li Xuejun for their contributions to the development of the Company during their tenure.
The Company actively pushed forward the development of policy-oriented businesses. Relying on its competitive advantages in professionalism and business scale, the Company continued to develop policy-oriented businesses including Supplementary Major Medical Insurance for Urban and Township Residents, New Village Cooperative Medical Insurance and New Rural Pension Insurance. The Companys inclusive businesses such as micro-insurance business realized nationwide coverage, and the insurance products designed for particular population groups such as senior citizens benefited over 10 million people. In addition, the Company provided insurance coverage for over 120,000 college-graduate village officials, and actively offered a career development platform for college-graduate village officials, with the number of the retired college-graduate village officials introduced to the Companys local branches amounting to over 1,000. The Company was constantly committed to the participation of public welfare and charitable undertakings. During the Reporting Period, the Company donated over RMB36 million through the China Life Foundation to provide support for several poverty alleviation projects and purchasing of medical vehicles in poverty-stricken areas. The Company also continually provided assistance for orphans from major disasters.
1 | Calculated according to the premium data of life insurance companies in 2015 released by the China Insurance Regulatory Commission (the CIRC). |
2
During the period of 12th Five-Year Plan, although the Company was confronted with the most complicated situation and the most challenges, it managed to overcome the difficulties and made progress in adjustment and transformation, laying a solid foundation for building a world-class life insurance company. The past five years helped us better recognize that the golden keys for opening up a new dimension of the Companys development were accelerating development by adhering to market orientation, optimizing structure by adhering to value guidance, improving service quality by emphasizing customer experience, enhancing information technology level by equipping the Company with high technologies, and strengthening local branches by building strong basis and solid foundation.
The year 2016 is the beginning of the 13th Five-Year Plan and also a critical year for the Company to comprehensively deepen the reforms and push forward the innovation-driven development strategy in great depth. Facing new challenges and development opportunities, the Company will concentrate efforts and resources, reinforce execution in accordance with the general requirements of the 13th Five-Year Plan, and strive to create a good beginning for its development during the 13th Five- Year Plan period. The Company will seek to accelerate the development of core businesses, push forward sales transformation, boost the development of comprehensive sales and interactive businesses, and actively expand policy-oriented businesses. The exclusive individual agent channel will focus on developing businesses of regular premiums with 10 years or longer payment duration as well as the distributed short-term insurance businesses. The group insurance channel will seek to maintain its current profitability while further expanding its business scale and improving the profits. The bancassurance channel will make more efforts in transformation and development of regular premium businesses with long payment duration, good value and high quality. Meanwhile, the development of new business channels will be enhanced by adhering to the combination of online and offline sales, integration of online, tele and mobile sales, and the direct sales over the counter will be continually promoted. The Company will continue to make strategic investment in the development of its sales force with an aim to improve the quantity and quality of the sales team and enhance the hard power. While reinforcing and improving its competitive advantages in county-level markets, the Company will further accelerate its business development in key cities, thus firmly maintaining its leading position in the market. As to the Companys investment level, we will focus on enhancing the investment capabilities, improving the asset allocation management system and investment management framework, and optimizing the asset allocation structure, so as to improve the level of investment income. The Company will further implement the innovation-driven development strategy, actively facilitate innovation in various fields, and push forward the construction of a new generation comprehensive business processing system with great efforts. By deepening its reforming progress, the Company will continue to enhance its development momentum. Moreover, the Company will be in full compliance with the requirements of China Risk Oriented Solvency System (C-ROSS), improve its effectiveness in risk control, strictly stick to the risk bottom line and steadily push forward the healthy and rapid development of the Company.
In retrospect, the development experiences accumulated during the 12th Five-Year Plan period are valuable; looking forward, the 13th Five-Year Plan period will present important opportunities for the Company to accelerate its development. The Company will stick to the general strategy of innovation- driven development and the main theme of transformation and upgrading, follow the operation ideas of emphasizing value, strengthening sales force, optimizing structure, achieving stable growth and guarding against risks, strengthen benchmarking practice and focus on making breakthroughs. The Company will also put more efforts in accelerating business development, transforming business model, deepening reforms and laying strong basis and solid foundation, so as to enable everyone to enjoy the high-quality services provided by the Company, to create greater value for investors, and to strive for building a world-class life insurance company.
3
MANAGEMENT DISCUSSION AND ANALYSIS
I | Business Overview of 2015 |
In 2015, the Company achieved a fast growth of its business and maintained its leading position in the market, with its business structure continuously optimized and the operating results noticeably improved. During the Reporting Period, the Companys net premiums earned was RMB362,301 million, an increase of 9.8% from 2014, with RMB308,081 million from life insurance business, increased by 7.9% from 2014, RMB40,855 million from health insurance business, increased by 25.2% from 2014, RMB13,365 million from accident insurance business, increased by 12.2% from 2014; first-year premiums for policies with insurance duration of more than one year increased by 20.1% from 2014, first-year regular premiums increased by 32.9% from 2014, and the percentage of first-year regular premiums in first-year premiums for policies with insurance duration of more than one year increased to 44.22% in 2015 from 39.94% in 2014; first-year regular premiums with 10 years or longer payment duration increased by 25.4% from 2014, and the percentage of first- year regular premiums with 10 years or longer payment duration in first-year regular premiums was 52.20%; renewal premiums increased by 1.9% from 2014, and the percentage of renewal premiums in gross written premiums was 52.64%. As at 31 December 2015, the number of in-force policies increased by 9.6% from the end of 2014; the Policy Persistency Rate (14 months and 26 months)2 reached 90.00% and 85.50%, respectively; and the Surrender Rate3 was 5.55%, a 0.09 percentage point increase from 2014.
With respect to the exclusive individual agent channel, the Company has achieved a relatively rapid increase in business scale and a remarkable increase in business value based on the continued business structure optimization. During the Reporting Period, gross written premiums from the exclusive individual agent channel increased by 10.0% year-on-year; first-year regular premiums increased by 39.2% year-on-year; the percentage of first-year regular premiums in first-year premiums was 98.97%; first-year regular premiums with 10 years or longer payment duration increased by 24.5% year-on-year; the percentages of first-year regular premiums with 5 years or longer payment duration and first-year regular premiums with 10 years or longer payment duration in gross first-year regular premiums were 90.50% and 61.15%, respectively; and renewal premiums increased by 3.9% year-on-year and the percentage of renewal premiums in gross written premiums of the exclusive individual agent channel was 75.96%. The Company has made significant achievements in its persistent implementation of the effective expansion strategy for team building. As at the end of the Reporting Period, the Company had a total of 979,000 exclusive individual agents which increased by 31.7% from the end of 2014. The Company continued to promote the professional development for the exclusive individual agent channel, and its sustainable development capacities have been enhanced remarkably.
2 | The Persistency Rate for long-term individual policy is an important operating performance indicator for life insurance companies. It measures the ratio of in-force policies in a pool of policies after a certain period of time. It refers to the proportion of policies that are still effective during the designated month in the pool of policies whose issue date was 14 or 26 months ago. |
3 | Surrender Rate = Surrender payment/(Liability of long-term insurance contracts at the beginning of the period + Premium of long-term insurance contracts) |
4
With respect to the group insurance channel, businesses maintained a steady growth. During the Reporting Period, gross written premiums from the group insurance channel increased by 15.3% year-on-year; short-term insurance premiums increased by 14.6% year-on-year and short-term accident insurance premiums increased by 12.5% year-on-year. The group insurance channel actively provided services for economic and social development, effectively pushed forward the development of micro-insurance business, insurance for college-graduate village officials, birth planning insurance, accident insurance for senior citizens and new village cooperative supplementary accident insurance, etc. The Company also actively developed the medical insurance business in the high-end market, and further operated the multinational co-insurance business and the international insurance business such as the travel insurance for Sino-Russian tourism. As at the end of the Reporting Period, the Company had a total of 45,000 group insurance sales representatives in the group insurance channel.
With respect to the bancassurance channel, the Company actively responded to new challenges from market competition by rapidly expanding the sales team, deepening cooperation between different sales channels and strengthening sales support, enhancing the fundamental management and promoting business development. While maintaining the business scale as well as the steady growth of regular premiums, the Company made great efforts in developing businesses with medium- to long-term regular premiums (particularly the regular premiums with 10 years or longer payment duration) and achieved remarkable results in its channel transformation. During the Reporting Period, gross written premiums from the bancassurance channel increased by 6.2% year-on-year, first-year premiums for policies with insurance duration of more than one year increased by 12.0% year-on-year, first-year regular premiums increased by 14.6% year-on-year, and first-year regular premiums with 10 years or longer payment duration increased by 35.9% year-on-year. As at the end of the Reporting Period, the number of intermediary bancassurance outlets was 56,000, with a total of 131,000 sales representatives which increased by 84.5% from the end of 2014.
In 2015, the Company improved its asset allocation capacity representing the core value and operation characteristics of life insurance, made continuous efforts in diversifying its investment products, channels and regions, and gradually formed a management structure, which was based on a strategic asset allocation, and relied on diversified and market-oriented investments with the entrustors active allocation and arrangement as well as the organization and implementation by the investment managers. In terms of investment portfolios, in regard to the falling interest rates, an unsteadily increasing bond market and the narrowed credit spread, the Company actively responded to the fixed income investment environment by increasing its allocation in transactional bonds and other financial products. Meanwhile, in view of the increasing fluctuations and distinct divisions of the stock market, the Company highly boosted market operations with the advantage of a market- oriented agency, and actively promoted allocation globally and made investments in sophisticated markets and high-quality assets while considering the prospective movement of exchange rate. As at the end of the Reporting Period, the Companys investment assets reached RMB2,287,639 million, an increase of 8.9% from the end of 2014. Among the major types of investments, the percentage of bonds was 43.55%, the percentage of term deposits was 24.59%, the percentage of stocks and funds4 was 9.34%, and the percentage of financial assets5, such as the debt investment plans, equity investment plans and trust schemes etc., was 5.26%. During the Reporting Period, interest and dividend income increased steadily, and net investment
4 | Exclusive of currency fund. |
5 | Including debt investment plans, equity investment plans, trust schemes, project asset-backed plans, asset-backed securities and specialized asset management plans, etc. |
5
yield6 was 4.30%. Spread income increased significantly, the gross investment yield was 6.24%, and the gross investment yield including net share of profit of associates and joint ventures7 was 6.20%. The comprehensive investment yield taking into account the current net fair value changes of available-for-sale financial assets recognized in other comprehensive income8 was 7.23%.
In 2015, the Company further implemented the innovation-driven development strategy. On the basis of further optimizing and improving its IT governance structure, the Company initiated the construction of the new generation comprehensive business processing system which featured as customer oriented, Internet-based, responsive and reliable. The Company fully promoted Cloud Assistant, Cloud Signage, Cloud Desktop and Total Internet Connection in order to speed up its mobile Internet-based operation. The Company stepped up the efforts in product innovation, further optimized its product development mechanism, and introduced several new products aimed at specific market segments and meeting customers emerging demands. The Company innovated a new mobile Internet-based sales model, which enabled a whole electronic process from product advertising, purchase, premium payment to policy generation. The Company further promoted the application of E-China Life and E-Store across sales channels, effectively promoting the sales of its major products. The Company reinforced the innovation of operation and services by launching E-customer Service with internet services and mobile app services as its core, marking a new beginning of the Companys Internet plus service. The nationwide promotion of Counter Pass system provided four-pass services of policy enquiry, claim acceptance, settlement and payment across provinces without geographical restrictions. The Company put more efforts in promoting centralized operation and realized centralized underwriting and claim assessment across eight provinces and municipalities, which accumulated precious experiences for the implementation of the Companys Rui Operation strategy. With automation rate of insurance underwriting and preservation reaching 74% and 81%, respectively, and the launch of a smart claim settlement platform, a pilot program of quick claim settlement and direct payment at hospitals, the Companys operational productivity and efficiency was further improved. The Company fully completed the promotion of comprehensive counter service system, with one-stop services becoming available at 2,578 counters nationwide. To improve customer experience, the Company launched global emergency services and VIP services for all long-term policy holders, which covered multi-layer and various classes of global emergency services, health consultation and VIP care services. The Company continued to support children education and development and participate in public welfare undertakings, and held painting and drawing events for children across China for five consecutive
6 | Net investment yield = (Investment income + Net income from investment properties - Business tax and extra charges for investment) / ((Investment assets at the beginning of the period + Investment assets at the end of the period) / 2) |
7 | Gross investment yield including net share of profit of associates and joint ventures = (Investment income + Net realised gains/(losses) on financial assets + Net fair value gains/(losses) through profit or loss + Total income from investment properties - Business tax and extra charges for investment + Net share of profit of associates and joint ventures) / ((Investment assets at the beginning of the period + Investments in associates and joint ventures at the beginning of the period + Investment assets at the end of the period + Investments in associates and joint ventures at the end of the period) / 2) |
8 | Comprehensive investment yield = (Investment income + Net realised gains/(losses) on financial assets + Net fair value gains/(losses) through profit or loss + Current net fair value changes of available-for-sale securities recognized in other comprehensive income + Total income from investment properties - Business tax and extra charges for investment) / ((Investment assets at the beginning of the period + Investment assets at the end of the period) / 2) |
6
years. The Company also cared about physical and mental health of customers, and actively held various customer activities, such as sports events and lectures, etc. The results of customer satisfaction and customer loyalty were increased by 1.2% and 4.8% year-on-year, reaching a record high.
The Company continuously complied with Section 404 of the U.S. Sarbanes-Oxley Act. Meanwhile, it implemented procedures for the compliance with standard systems of corporate internal control by following the Standard Regulations on Corporate Internal Control and the Implementation Guidelines for Corporate Internal Control jointly issued by five PRC ministries including the Ministry of Finance, etc, and the Basic Standards of Internal Control for Insurance Companies issued by the CIRC. In addition, the Company updated and benchmarked its internal control system to the Internal Control-Integrated Framework (2013) issued by the U.S. Committee of Sponsoring Organizations (COSO). In accordance with the CIRCs requirements on the commissioning in the C-ROSS transition period, the Company launched programs to build up its solvency risk management system, fully benchmarked itself to the regulatory rules, strengthened the soundness, compliance and validity of its risk management system, and optimized the formation and transmission mechanisms of risk preference. The Company complied with the Guidelines for the Implementation of Comprehensive Risk Management of Life Insurance Companies issued by the CIRC, continued the work in relation to risk alert classification management, and created a monitoring system on key risks and explored a remote and vertical monitoring mode based on its information system. The Company also took the opportunity of the CIRCs special inspection, namely two strengthens and two containments, to identify internal control problems and make effective adjustments. All the above measures helped to improve the Companys risk management framework, secure the risk bottom line and optimize the internal control process, which enhanced the Companys capability in risk management.
II | Analysis of Major Items of Consolidated Statement of Comprehensive Income |
(1) | Total Revenues |
For the year ended 31 December | RMB million | |||||||
2015 | 2014 | |||||||
Net premiums earned |
362,301 | 330,105 | ||||||
Life insurance business |
308,081 | 285,574 | ||||||
Health insurance business |
40,855 | 32,624 | ||||||
Accident insurance business |
13,365 | 11,907 | ||||||
Investment income |
97,582 | 93,548 | ||||||
Net realised gains on financial assets |
32,297 | 7,120 | ||||||
Net fair value gains through profit or loss |
10,209 | 5,808 | ||||||
Other income |
5,060 | 4,185 | ||||||
|
|
|
|
|||||
Total |
507,449 | 440,766 | ||||||
|
|
|
|
7
Net Premiums Earned
1 | Life Insurance Business |
During the Reporting Period, net premiums earned from life insurance business increased by 7.9% year-on-year. This was primarily due to an increase in the first-year premiums for policies with insurance duration of more than one year resulting from the Companys enhanced efforts in team building and business development.
2 | Health Insurance Business |
During the Reporting Period, net premiums earned from health insurance business increased by 25.2% year-on-year. This was primarily due to the Companys enhanced efforts in developing health insurance business.
3 | Accident Insurance Business |
During the Reporting Period, net premiums earned from accident insurance business increased by 12.2% year-on-year. This was primarily due to the Companys continuous efforts in developing accident insurance business.
Gross written premiums categorized by business:
For the year ended 31 December |
RMB million |
|||||||
2015 | 2014 | |||||||
Life Insurance Business |
308,169 | 285,619 | ||||||
First-year business |
134,449 | 111,346 | ||||||
Single |
78,068 | 70,006 | ||||||
First-year regular |
56,381 | 41,340 | ||||||
Renewal business |
173,720 | 174,273 | ||||||
Health Insurance Business |
42,041 | 33,192 | ||||||
First-year business |
24,435 | 19,525 | ||||||
Single |
18,993 | 14,459 | ||||||
First-year regular |
5,442 | 5,066 | ||||||
Renewal business |
17,606 | 13,667 | ||||||
Accident Insurance Business |
13,761 | 12,199 | ||||||
First-year business |
13,480 | 12,049 | ||||||
Single |
13,403 | 11,888 | ||||||
First-year regular |
77 | 161 | ||||||
Renewal business |
281 | 150 | ||||||
|
|
|
|
|||||
Total |
363,971 | 331,010 | ||||||
|
|
|
|
8
Gross written premiums categorized by channel:
For the year ended 31 December |
RMB million |
|||||||
2015 | 2014 | |||||||
Exclusive Individual Agent Channel |
225,957 | 205,417 | ||||||
First-year business of long-term insurance |
47,974 | 34,455 | ||||||
Single |
495 | 335 | ||||||
First-year regular |
47,479 | 34,120 | ||||||
Renewal business |
171,632 | 165,131 | ||||||
Short-term insurance business |
6,351 | 5,831 | ||||||
Group Insurance Channel |
20,107 | 17,440 | ||||||
First-year business of long-term insurance |
3,571 | 2,989 | ||||||
Single |
3,372 | 2,878 | ||||||
First-year regular |
199 | 111 | ||||||
Renewal business |
553 | 506 | ||||||
Short-term insurance business |
15,983 | 13,945 | ||||||
Bancassurance Channel |
106,028 | 99,825 | ||||||
First-year business of long-term insurance |
87,222 | 77,881 | ||||||
Single |
73,508 | 65,918 | ||||||
First-year regular |
13,714 | 11,963 | ||||||
Renewal business |
18,558 | 21,815 | ||||||
Short-term insurance business |
248 | 129 | ||||||
Other Channels1 |
11,879 | 8,328 | ||||||
First-year business of long-term insurance |
1,209 | 1,262 | ||||||
Single |
701 | 889 | ||||||
First-year regular |
508 | 373 | ||||||
Renewal business |
864 | 638 | ||||||
Short-term insurance business |
9,806 | 6,428 | ||||||
|
|
|
|
|||||
Total |
363,971 | 331,010 | ||||||
|
|
|
|
Notes:
1. | Other channels mainly include supplementary major medical insurance business, telephone sales, etc. |
2. | The Companys channel premium breakdown was presented based on the separate groups of sales personnels including exclusive individual agent team, direct sales representatives, bancassurance sales team, and other distribution channels. |
9
Investment Income
For the year ended 31 December | RMB million | |||||||
2015 | 2014 | |||||||
Investment income from securities at fair value through profit or loss |
1,708 | 1,677 | ||||||
Investment income from available-for-sale securities |
27,476 | 23,029 | ||||||
Investment income from held-to-maturity securities |
24,541 | 25,357 | ||||||
Investment income from bank deposits |
32,285 | 34,934 | ||||||
Investment income from loans |
11,115 | 8,138 | ||||||
Other investment income |
457 | 413 | ||||||
|
|
|
|
|||||
Total |
97,582 | 93,548 | ||||||
|
|
|
|
1 | Investment Income from Securities at Fair Value through Profit or Loss |
During the Reporting Period, investment income from securities at fair value through profit or loss increased by 1.8% year-on-year. This was primarily due to an increase in dividend income from stocks at fair value through profit or loss.
2 | Investment Income from Available-for-Sale Securities |
During the Reporting Period, investment income from available-for-sale securities increased by 19.3% year-on-year. This was primarily due to an increase in dividend income from available-for-sale funds, wealth management products and other equity investments.
3 | Investment Income from Held-to-Maturity Securities |
During the Reporting Period, investment income from held-to-maturity securities decreased by 3.2% year-on-year. This was primarily due to a decrease in the allocation of treasury bonds.
4 | Investment Income from Bank Deposits |
During the Reporting Period, investment income from bank deposits decreased by 7.6% year-on-year. This was primarily due to a decrease in the allocation of negotiated deposits and the investment yield of newly increased allocation under the low interest rate environment.
10
5 | Investment Income from Loans |
During the Reporting Period, investment income from loans increased by 36.6% year-on- year. This was primarily due to an increase in the scale of policy loans and trust schemes, etc.
Net Realised Gains on Financial Assets
During the Reporting Period, net realised gains on financial assets increased by 353.6% year-on- year. This was primarily due to a significant increase in the spread income of available-for-sale stocks and funds.
Net Fair Value Gains through Profit or Loss
During the Reporting Period, net fair value gains through profit or loss increased by 75.8% year-on-year. This was primarily due to a significant increase in the spread income of stocks at fair value through profit of loss.
Other Income
During the Reporting Period, other income increased by 20.9% year-on-year. This was primarily due to an increase in the commission fees earned from China Life Property and Casualty Insurance Company Limited resulting from the Companys increased efforts in promoting its interactive business.
(2) | Benefits, Claims and Expenses |
For the year ended 31 December | RMB million | |||||||
2015 | 2014 | |||||||
Insurance benefits and claims expenses |
352,219 | 315,294 | ||||||
Life insurance business |
313,612 | 288,868 | ||||||
Health insurance business |
34,398 | 22,434 | ||||||
Accident insurance business |
4,209 | 3,992 | ||||||
Investment contract benefits |
2,264 | 1,958 | ||||||
Policyholder dividends resulting from participation in profits |
33,491 | 24,866 | ||||||
Underwriting and policy acquisition costs |
35,569 | 27,147 | ||||||
Finance costs |
4,320 | 4,726 | ||||||
Administrative expenses |
27,458 | 25,432 | ||||||
Other expenses |
7,428 | 4,151 | ||||||
Statutory insurance fund contribution |
743 | 701 | ||||||
|
|
|
|
|||||
Total |
463,492 | 404,275 | ||||||
|
|
|
|
11
Insurance Benefits and Claims Expenses
1 | Life Insurance Business |
During the Reporting Period, insurance benefits and claims expenses attributable to life insurance business increased by 8.6% year-on-year. This was primarily due to an increase in the scale of life insurance business.
2 | Health Insurance Business |
During the Reporting Period, insurance benefits and claims expenses attributable to health insurance business increased by 53.3% year-on-year. This was primarily due to an increase in the scale of health insurance business and the update of actuarial assumptions, such as discount rate assumption of reserves of traditional insurance contracts.
3 | Accident Insurance Business |
During the Reporting Period, insurance benefits and claims expenses attributable to accident insurance business increased by 5.4% year-on-year. This was primarily due to an increase in the scale of accident insurance business.
Investment Contract Benefits
During the Reporting Period, investment contract benefits increased by 15.6% year-on-year. This was primarily due to an increase in the scale of investment contracts.
Policyholder Dividends Resulting from Participation in Profits
During the Reporting Period, policyholder dividends resulting from participation in profits increased by 34.7% year-on-year. This was primarily due to an increase in investment yields of the participating products.
Underwriting and Policy Acquisition Costs
During the Reporting Period, underwriting and policy acquisition costs increased by 31.0% year-on-year. This was primarily due to an increase in underwriting costs for first-year regular premium business resulting from the growth of the Companys business and the optimization of its business structure.
12
Finance Costs
During the Reporting Period, finance costs decreased by 8.6% year-on-year. This was primarily due to a decrease in interest payments for securities sold under agreements to repurchase.
Administrative Expenses
During the Reporting Period, administrative expenses increased by 8.0% year-on-year. This was primarily due to the Companys increased investment in team building for the purpose of enhancing its sustainable development capacity.
Other Expenses
During the Reporting Period, other expenses increased by 78.9% year-on-year. This was primarily due to an increase in business taxes and surcharges expenses resulting from an increase in taxable income from investments.
(3) | Profit before Income Tax |
For the year ended 31 December | RMB million | |||||||
2015 |
2014 | |||||||
Life insurance business |
40,921 | 30,651 | ||||||
Health insurance business |
557 | 3,252 | ||||||
Accident insurance business |
1,753 | 1,546 | ||||||
Other business |
2,700 | 4,953 | ||||||
|
|
|
|
|||||
Total |
45,931 | 40,402 | ||||||
|
|
|
|
1 | Life Insurance Business |
During the Reporting Period, profit before income tax in life insurance business increased by 33.5% year-on-year. This was primarily due to the growth of business and an increase in income from investments as compared to the corresponding period of 2014.
13
2 | Health Insurance Business |
During the Reporting Period, profit before income tax in health insurance business decreased by 82.9% year-on-year. This was primarily due to the update of actuarial assumptions, such as discount rate assumption of reserves of traditional insurance contracts, which partially reduced the profit for the period.
3 | Accident Insurance Business |
During the Reporting Period, profit before income tax in accident insurance business increased by 13.4% year-on-year. This was primarily due to an increase in the scale of accident insurance business as compared to the corresponding period of 2014.
4 | Other Business |
During the Reporting Period, profit before income tax in other business decreased by 45.5% year-on-year. This was primarily due to a decrease in net profits of associates and the impairment of investments in associates.
(4) | Income Tax |
During the Reporting Period, income tax of the Company was RMB10,744 million, a 36.2% increase year-on-year. This was primarily due to an increase in profit before income tax.
(5) | Net Profit |
During the Reporting Period, net profit attributable to equity holders of the Company was RMB34,699 million, a 7.7% increase year-on-year. This was mainly attributable to factors such as the increase in investment income. However, update of actuarial assumptions, such as discount rate assumption of reserves of traditional insurance contracts, partially reduced the profit for the period.
14
III | Analysis of Major Items of Consolidated Statement of Financial Position |
(1) | Major Assets |
RMB million |
||||||||
As at 31 December 2015 |
As at 31 December 2014 |
|||||||
Investment assets |
2,287,639 | 2,100,870 | ||||||
Term deposits |
562,622 | 690,156 | ||||||
Held-to-maturity securities |
504,075 | 517,283 | ||||||
Available-for-sale securities |
770,516 | 607,531 | ||||||
Securities at fair value through profit or loss |
137,990 | 53,052 | ||||||
Securities purchased under agreements to resell |
21,503 | 11,925 | ||||||
Cash and cash equivalents |
76,096 | 47,034 | ||||||
Loans |
207,267 | 166,453 | ||||||
Statutory deposits restricted |
6,333 | 6,153 | ||||||
Investment properties |
1,237 | 1,283 | ||||||
Other assets |
160,676 | 145,697 | ||||||
|
|
|
|
|||||
Total |
2,448,315 | 2,246,567 | ||||||
|
|
|
|
Term Deposits
As at the end of the Reporting Period, term deposits decreased by 18.5% year-on-year. This was primarily due to a decrease in the allocation of negotiated deposits.
Held-to-Maturity Securities
As at the end of the Reporting Period, held-to-maturity securities decreased by 2.6% year-on- year. This was primarily due to a decrease in the allocation of treasury bonds.
Available-for-Sale Securities
As at the end of the Reporting Period, available-for-sale securities increased by 26.8% year- on-year. This was primarily due to an increase in the allocation of funds, wealth management products and unlisted equities in light of market conditions in a timely manner.
15
Securities at Fair Value through Profit or Loss
As at the end of the Reporting Period, securities at fair value through profit or loss increased by 160.1% year-on-year. This was primarily due to an increase in the allocation of bonds at fair value through profit or loss.
Cash and Cash Equivalents
As at the end of the Reporting Period, cash and cash equivalents increased by 61.8% year-on- year. This was primarily due to the needs for liquidity management.
Loans
As at the end of the Reporting Period, loans increased by 24.5% year-on-year. This was primarily due to an increase in the scale of policy loans and trust schemes, etc.
Investment Properties
As at the end of the Reporting Period, investment properties decreased by 3.6% year-on-year. This was primarily due to the depreciation of the investment properties.
As at the end of the Reporting Period, our investment assets are categorized as below in terms of asset classes:
RMB million | ||||||||||||||||
As at 31 December 2015 | As at 31 December 2014 |
|||||||||||||||
Amount | Percentage | Amount | Percentage | |||||||||||||
Fixed-maturity investments |
1,777,180 | 77.69 | % | 1,804,598 | 85.90 | % | ||||||||||
Term deposits |
562,622 | 24.59 | % | 690,156 | 32.85 | % | ||||||||||
Bonds |
996,236 | 43.55 | % | 940,619 | 44.77 | % | ||||||||||
Insurance asset management products1 |
67,569 | 2.95 | % | 62,348 | 2.97 | % | ||||||||||
Other fixed-maturity investments 2 |
150,753 | 6.60 | % | 111,475 | 5.31 | % | ||||||||||
Equity investments |
411,623 | 17.99 | % | 236,030 | 11.23 | % | ||||||||||
Common stocks |
111,516 | 4.87 | % | 94,933 | 4.52 | % | ||||||||||
Funds |
169,485 | 7.41 | % | 83,620 | 3.98 | % | ||||||||||
Other equity investments3 |
130,622 | 5.71 | % | 57,477 | 2.73 | % | ||||||||||
Investment properties |
1,237 | 0.05 | % | 1,283 | 0.06 | % | ||||||||||
Cash, cash equivalents and others 4 |
97,599 | 4.27 | % | 58,959 | 2.81 | % | ||||||||||
|
|
|
|
|
|
|
|
|||||||||
Total |
2,287,639 | 100.00 | % | 2,100,870 | 100.00 | % | ||||||||||
|
|
|
|
|
|
|
|
16
Notes:
1. | Insurance asset management products under fixed-maturity investments include infrastructure and real estate debt investment plans and project asset-backed plans. |
2. | Other fixed-maturity investments include policy loans, trust schemes, statutory deposits restricted, etc. |
3. | Other equity investments include private equity funds, unlisted equities, preference stocks, equity investment plans, wealth management products, etc. |
4. | Cash, cash equivalents and others include cash and cash equivalents, and securities purchased under agreements to resell. |
(2) | Major Liabilities |
RMB million | ||||||||
As at | As at | |||||||
31 December | 31 December | |||||||
2015 | 2014 | |||||||
Insurance contracts |
1,715,985 | 1,603,446 | ||||||
Investment contracts |
84,106 | 72,275 | ||||||
Securities sold under agreements to repurchase |
31,354 | 46,089 | ||||||
Policyholder dividends payable |
107,774 | 74,745 | ||||||
Annuity and other insurance balances payable |
30,092 | 25,617 | ||||||
Interest-bearing loans and borrowings |
2,643 | 2,623 | ||||||
Bonds payable |
67,994 | 67,989 | ||||||
Deferred tax liabilities |
16,953 | 19,375 | ||||||
Other liabilities |
65,200 | 47,077 | ||||||
|
|
|
|
|||||
Total |
2,122,101 | 1,959,236 | ||||||
|
|
|
|
Insurance Contracts
As at the end of the Reporting Period, insurance contracts liabilities increased by 7.0% year- on-year. This was primarily due to the accumulation of insurance liabilities from new insurance business and renewal business. As at the date of the statement of financial position, the Companys insurance contracts reserves passed liability adequacy testing.
Investment Contracts
As at the end of the Reporting Period, account balance of investment contracts increased by 16.4% year-on-year. This was primarily due to an increase in the scale of certain investment contracts.
17
Securities Sold under Agreements to Repurchase
As at the end of the Reporting Period, securities sold under agreements to repurchase decreased by 32.0% year-on-year. This was primarily due to the needs for liquidity management.
Policyholder Dividends Payable
As at the end of the Reporting Period, policyholder dividends payable increased by 44.2% year- on-year. This was primarily due to an increase in investment yields of participating products.
Annuity and Other Insurance Balances Payable
As at the end of the Reporting Period, annuity and other insurance balances payable increased by 17.5% year-on-year. This was primarily due to an increase in maturities payable.
Interest-bearing Loans and Borrowings
As at the end of the Reporting Period, interest-bearing loans and borrowings remained stable compared to the end of 2014, and there were no new loans and borrowings in 2015. In June 2014, to meet the needs of overseas investment, one of the Companys subsidiaries applied for a fixed-interest rate bank loan of GBP275 million with a term of five years. As at the end of the Reporting Period, the loan balance was equivalent to RMB2,643 million.
Bonds Payable
As at the end of the Reporting Period, bonds payable remained stable compared to the end of 2014. This was primarily due to the fact that no subordinated debts were issued by the Company in 2015.
Deferred Tax Liabilities
As at the end of the Reporting Period, deferred tax liabilities decreased by 12.5% year-on-year. This was primarily due to an increase in the deductible temporary differences.
(3) | Equity Holders Equity |
As at the end of the Reporting Period, equity holders equity was RMB322,492 million, a 13.5% increase year-on-year. This was primarily due to the combined effect of an increase in the fair value of available-for-sale financial assets and the profit earned during the Reporting Period.
18
IV | Analysis of Cash Flows |
(1) | Liquidity Sources |
Our principal cash inflows come from insurance premiums, deposits from investment contracts, proceeds from sales and maturity of investment assets, and investment income. The primary liquidity risks with respect to these cash inflows are the risk of early withdrawals by contract holders and policyholders, as well as the risks of default by debtors, interest rate changes and other market volatilities. We closely monitor and manage these risks.
Our cash and bank deposits can provide us with a source of liquidity to meet normal cash outflows. As at the end of the Reporting Period, the amount of cash and cash equivalents was RMB76,096 million. In addition, substantially all of our term deposits with banks allow us to withdraw funds on deposit, subject to a penalty interest charge. As at the end of the Reporting Period, the amount of term deposits was RMB562,622 million.
Our investment portfolio also provides us with a source of liquidity to meet unexpected cash outflows. We are also subject to market liquidity risk due to the large size of our investments in some of the markets in which we invest. In some circumstances, some of our holdings of investment securities may be large enough to have an influence on the market value. These factors may adversely affect our ability to sell these investments or sell them at a fair price.
(2) | Liquidity Uses |
Our principal cash outflows primarily relate to the payables for the liabilities associated with our various life insurance, annuity, accident insurance and health insurance products, operating expenses, income taxes and dividends that may be declared and paid to our equity holders. Cash outflows arising from our insurance activities primarily relate to benefit payments under these insurance products, as well as payments for policy surrenders, withdrawals and loans.
We believe that our sources of liquidity are sufficient to meet our current cash requirements.
(3) | Consolidated Cash Flows |
For the year ended 31 December | RMB million | |||||||
2015 | 2014 | |||||||
Net cash inflow/(outflow) from operating activities |
(18,811 | ) | 78,247 | |||||
Net cash inflow/(outflow) from investing activities |
67,047 | (69,257 | ) | |||||
Net cash inflow/(outflow) from financing activities |
(19,415 | ) | 16,704 | |||||
Foreign exchange gains on cash and cash equivalents |
241 | 10 | ||||||
|
|
|
|
|||||
Net increase in cash and cash equivalents |
29,062 | 25,704 | ||||||
|
|
|
|
19
We have established a cash flow testing system. We conduct regular tests to monitor the cash inflows and outflows under various changing circumstances and adjust accordingly the asset portfolio to ensure sufficient sources of liquidity. During the Reporting Period, the change of net cash flow from operating activities was primarily due to an increase in securities at fair value through profit or loss. The change of net cash flow from investing activities was primarily due to the needs for investment management. The change in net cash flow from financing activities was primarily due to the needs for liquidity management.
V | Solvency Ratio |
The solvency ratio of an insurance company is a measure of capital adequacy, which is calculated by dividing the actual capital of the company (which is its admitted assets less admitted liabilities, determined in accordance with relevant regulatory rules) by the minimum required capital. The following table shows our solvency ratio as at the end of the Reporting Period:
RMB million | ||||||||
As at 31 December |
As at 31 December |
|||||||
2015 | 2014 | |||||||
Actual capital |
282,820 | 236,151 | ||||||
Minimum capital |
85,676 | 80,193 | ||||||
Solvency ratio |
330.10 | % | 294.48 | % | ||||
|
|
|
|
The increase in the Companys solvency ratio was primarily due to a significant increase in the comprehensive income during the Reporting Period and the issue of Core Tier 2 Capital Securities.
20
ANNUAL RESULTS9
CONSOLIDATED STATEMENT OF COMPREHENSIVE INCOME
For the year ended 31 December 2015
Notes | 2015 RMB million |
2014 RMB million |
||||||||||
REVENUES |
||||||||||||
Gross written premiums |
363,971 | 331,010 | ||||||||||
Less: premiums ceded to reinsurers |
(978 | ) | (515 | ) | ||||||||
|
|
|
|
|||||||||
Net written premiums |
362,993 | 330,495 | ||||||||||
Net change in unearned premium reserves |
(692 | ) | (390 | ) | ||||||||
|
|
|
|
|||||||||
Net premiums earned |
362,301 | 330,105 | ||||||||||
|
|
|
|
|||||||||
Investment income |
1 | 97,582 | 93,548 | |||||||||
Net realised gains on financial assets |
2 | 32,297 | 7,120 | |||||||||
Net fair value gains through profit or loss |
3 | 10,209 | 5,808 | |||||||||
Other income |
5,060 | 4,185 | ||||||||||
|
|
|
|
|||||||||
Total revenues |
507,449 | 440,766 | ||||||||||
|
|
|
|
|||||||||
BENEFITS, CLAIMS AND EXPENSES |
||||||||||||
Insurance benefits and claims expenses |
||||||||||||
Life insurance death and other benefits |
4 | (221,701 | ) | (192,659 | ) | |||||||
Accident and health claims and claim adjustment expenses |
4 | (21,009 | ) | (16,752 | ) | |||||||
Increase in insurance contract liabilities |
4 | (109,509 | ) | (105,883 | ) | |||||||
Investment contract benefits |
5 | (2,264 | ) | (1,958 | ) | |||||||
Policyholder dividends resulting from participation in profits |
(33,491 | ) | (24,866 | ) | ||||||||
Underwriting and policy acquisition costs |
(35,569 | ) | (27,147 | ) | ||||||||
Finance costs |
6 | (4,320 | ) | (4,726 | ) | |||||||
Administrative expenses |
(27,458 | ) | (25,432 | ) | ||||||||
Other expenses |
(7,428 | ) | (4,151 | ) | ||||||||
Statutory insurance fund contribution |
7 | (743 | ) | (701 | ) | |||||||
|
|
|
|
|||||||||
Total benefits, claims and expenses |
(463,492 | ) | (404,275 | ) | ||||||||
|
|
|
|
|||||||||
Share of profit of associates and joint ventures, net |
8 | 1,974 | 3,911 | |||||||||
|
|
|
|
|||||||||
Profit before income tax |
9 | 45,931 | 40,402 | |||||||||
Income tax |
10 | (10,744 | ) | (7,888 | ) | |||||||
|
|
|
|
|||||||||
Net profit |
35,187 | 32,514 | ||||||||||
|
|
|
|
|||||||||
Attributable to: |
||||||||||||
Equity holders of the Company |
34,699 | 32,211 | ||||||||||
Non-controlling interests |
488 | 303 | ||||||||||
Basic and diluted earnings per share |
11 | RMB1.22 | RMB1.14 | |||||||||
|
|
|
|
9 | The Group refers to China Life Insurance Company Limited and its subsidiaries in this part. |
21
CONSOLIDATED STATEMENT OF COMPREHENSIVE INCOME (Continued)
For the year ended 31 December 2015
2015 | 2014 | |||||||||||
Note | RMB million | RMB million | ||||||||||
Other comprehensive income |
||||||||||||
Other comprehensive income that may be reclassified to profit or loss in subsequent periods: |
||||||||||||
Fair value gains on available-for-sale securities |
54,080 | 70,342 | ||||||||||
Amount transferred to net profit from other comprehensive income |
(32,297 | ) | (7,120 | ) | ||||||||
Portion of fair value changes on available-for-sale securities attributable to participating policyholders |
(12,767 | ) | (11,035 | ) | ||||||||
Share of other comprehensive income of associates and joint ventures under the equity method |
353 | 120 | ||||||||||
Exchange differences on translating foreign operations |
10 | | ||||||||||
Income tax relating to components of other comprehensive income |
10 | (2,242 | ) | (13,023 | ) | |||||||
|
|
|
|
|||||||||
Other comprehensive income that may be reclassified to profit or loss in subsequent periods |
7,137 | 39,284 | ||||||||||
|
|
|
|
|||||||||
Other comprehensive income that will not be reclassified to profit or loss in subsequent periods |
| | ||||||||||
|
|
|
|
|||||||||
Other comprehensive income for the year, net of tax |
7,137 | 39,284 | ||||||||||
|
|
|
|
|||||||||
Total comprehensive income for the year, net of tax |
42,324 | 71,798 | ||||||||||
|
|
|
|
|||||||||
Attributable to: |
||||||||||||
Equity holders of the Company |
41,775 | 71,443 | ||||||||||
Non-controlling interests |
549 | 355 | ||||||||||
|
|
|
|
22
Notes:
1 | INVESTMENT INCOME |
For the year ended 31 December | ||||||||
2015 | 2014 | |||||||
RMB million | RMB million | |||||||
Debt securities |
||||||||
held-to-maturity securities |
24,541 | 25,357 | ||||||
available-for-sale securities |
18,526 | 18,571 | ||||||
at fair value through profit or loss |
1,382 | 1,571 | ||||||
Equity securities |
||||||||
available-for-sale securities |
8,950 | 4,458 | ||||||
at fair value through profit or loss |
326 | 106 | ||||||
Bank deposits |
32,285 | 34,934 | ||||||
Loans |
11,115 | 8,138 | ||||||
Securities purchased under agreements to resell |
368 | 299 | ||||||
Others |
89 | 114 | ||||||
|
|
|
|
|||||
Total |
97,582 | 93,548 | ||||||
|
|
|
|
For the year ended 31 December 2015, the interest income included in investment income was RMB88,306 million (2014: RMB88,984 million). All interest income was accrued using the effective interest method.
2 | NET REALISED GAINS ON FINANCIAL ASSETS |
For the year ended 31 December | ||||||||
2015 | 2014 | |||||||
RMB million | RMB million | |||||||
Debt securities |
||||||||
Realised gains |
(4 | ) | 142 | |||||
Reversal of impairment |
| | ||||||
|
|
|
|
|||||
Subtotal |
(4 | ) | 142 | |||||
|
|
|
|
|||||
Equity securities |
||||||||
Realised gains |
32,622 | 8,127 | ||||||
Impairment |
(321 | ) | (1,149 | ) | ||||
|
|
|
|
|||||
Subtotal |
32,301 | 6,978 | ||||||
|
|
|
|
|||||
Total |
32,297 | 7,120 | ||||||
|
|
|
|
Net realised gains on financial assets are from available-for-sale securities.
During the year ended 31 December 2015, the Group recognised an impairment charge of RMB147 million (2014: RMB146 million) of available-for-sale funds, an impairment charge of RMB174 million (2014: RMB1,003 million) of available-for-sale common stocks, and no impairment charge (2014: Nil) of other available-for-sale securities, for which the Group determined that objective evidence of impairment existed.
23
3 | NET FAIR VALUE GAINS THROUGH PROFIT OR LOSS |
For the year ended 31 December | ||||||||
2015 RMB million |
2014 RMB million |
|||||||
Debt securities |
766 | 2,272 | ||||||
Equity securities |
9,324 | 4,977 | ||||||
Stock appreciation rights |
180 | (255 | ) | |||||
Financial liabilities at fair value through profit or loss |
(61 | ) | (1,186 | ) | ||||
|
|
|
|
|||||
Total |
10,209 | 5,808 | ||||||
|
|
|
|
4 | INSURANCE BENEFITS AND CLAIMS EXPENSES |
Gross RMB million |
Ceded RMB million |
Net RMB million |
||||||||||
For the year ended 31 December 2015 |
||||||||||||
Life insurance death and other benefits |
221,949 | (248 | ) | 221,701 | ||||||||
Accident and health claims and claim adjustment expenses |
21,166 | (157 | ) | 21,009 | ||||||||
Increase in insurance contract liabilities |
109,847 | (338 | ) | 109,509 | ||||||||
|
|
|
|
|
|
|||||||
Total |
352,962 | (743 | ) | 352,219 | ||||||||
|
|
|
|
|
|
|||||||
For the year ended 31 December 2014 |
||||||||||||
Life insurance death and other benefits |
192,863 | (204 | ) | 192,659 | ||||||||
Accident and health claims and claim adjustment expenses |
16,854 | (102 | ) | 16,752 | ||||||||
Increase in insurance contract liabilities |
105,945 | (62 | ) | 105,883 | ||||||||
|
|
|
|
|
|
|||||||
Total |
315,662 | (368 | ) | 315,294 | ||||||||
|
|
|
|
|
|
5 | INVESTMENT CONTRACT BENEFITS |
Benefits of investment contracts are mainly the interest credited to investment contracts.
24
6 | FINANCE COSTS |
For the year ended 31 December | ||||||||
2015 | 2014 | |||||||
RMB million | RMB million | |||||||
Interest expenses for bonds payable |
3,430 | 3,433 | ||||||
Interest expenses for securities sold under agreements to repurchase |
784 | 1,234 | ||||||
Interest expenses for interest-bearing loans and borrowings |
106 | 59 | ||||||
|
|
|
|
|||||
Total |
4,320 | 4,726 | ||||||
|
|
|
|
7 | STATUTORY INSURANCE FUND |
As required by the CIRC Order [2008] No. 2, Measures for Administration of Statutory Insurance Fund, all insurance companies have to pay the statutory insurance fund contribution to the CIRC from 1 January 2009. The Group is subject to the statutory insurance fund contribution, (i) at 0.15% and 0.05% of premiums and accumulated policyholder deposits from life policies with guaranteed benefits and life policies without guaranteed benefits, respectively; (ii) at 0.8% and 0.15% of premiums from short-term health policies and long-term health policies, respectively; (iii) at 0.8% of premiums from accident insurance contracts, at 0.08% and 0.05% of accumulated policyholder deposits from accident investment contracts with guaranteed benefits and without guaranteed benefits, respectively. When the accumulated statutory insurance fund contributions reach 1% of total assets, no additional contribution to the statutory insurance fund is required.
8 | INVESTMENTS IN ASSOCIATES AND JOINT VENTURES |
2015 | 2014 | |||||||
RMB million | RMB million | |||||||
As at 1 January |
44,390 | 34,775 | ||||||
Investments in associates and joint ventures |
766 | 5,671 | ||||||
Scrip dividend |
| 268 | ||||||
Share of profit |
2,984 | 3,911 | ||||||
Other equity movements |
649 | 280 | ||||||
Dividend received (i) |
(604 | ) | (515 | ) | ||||
Impairment (ii) |
(1,010 | ) | | |||||
|
|
|
|
|||||
As at 31 December |
47,175 | 44,390 | ||||||
|
|
|
|
25
(i) | 2014 final dividend of HKD0.165 per ordinary share was approved and declared in the annual general meeting of Sino-Ocean Land Holdings Limited (Sino-Ocean) on 12 May 2015. On 22 May 2015, Sino-Ocean made the announcement of scrip dividend plan, according to which the shareholders could elect to receive the 2014 final dividend in cash or in scrip shares. The Company elected the cash option and received cash dividend amounting to RMB286 million. 2015 interim dividend of HKD0.075 per ordinary share was approved and declared in the board meeting of Sino-Ocean on 21 August 2015, and each shareholder could elect to receive the 2015 interim dividend in cash or in scrip shares. The Company elected the cash option and received cash dividend amounting to RMB136 million. |
(ii) | The Groups investments in associates and joint ventures are unlisted except for Sino-Ocean, which is listed in Hong Kong. As at 31 December 2015, the stock price of Sino-Ocean was HKD4.97 per share. As its business performance declined in 2015, and the quoted market price of Sino-Ocean (stock price per share multiplies shares held by the Group) was below the carrying value for more than one year, the Group performed an impairment test to this investment. As at 31 December 2015, the recoverable amount of this investment valued using the discounted future cash flow method was approximately RMB12.40 billion and therefore an impairment loss of RMB1.01 billion was made for this investment in 2015. In the valuation, the Group separated the development property and investment property by considering the different future cash flow features. The discount rates applied in the valuation were 10% and 8% for development property and investment property, respectively. The impairment for this investment is included in Share of profit of associates and joint ventures, net in the consolidated statement of comprehensive income. |
As at 31 December 2015, the Group owned the following associates and joint ventures:
Country of | Percentage of | |||||||
Name |
incorporation | equity interest held | ||||||
Associates |
||||||||
China Guangfa Bank Co., Ltd (CGB) |
PRC | 20.00 | % | |||||
China Life Property & Casualty Insurance Company Limited (CLP&C) |
PRC | 40.00 | % | |||||
Sino-Ocean |
Hong Kong, PRC | 29.998 | % | |||||
COFCO Futures Company Limited (COFCO Futures) |
PRC | 35.00 | % | |||||
Annoroad Gene Technology (Beijing) Co., Ltd. (Annoroad Technology)(i) |
PRC | 16.67 | % | |||||
Joint ventures |
||||||||
10 Upper Bank Street SLP |
Jersey Island | 70.00 | % | |||||
China Life (Sanya) Healthy Investment Company Limited (Sanya Company)(ii) |
PRC | 51.00 | % |
(i) | In June 2015, the Group contributed RMB250 million in Annoroad Technology, holding 16.67% of its equity interests. According to the provisions of the agreement, the Group can impose a significant influence over Annoroad Technologys financial and operating decisions through its general meeting and board of directors and therefore accounted for it as an associate. |
(ii) | In December 2015, the Group contributed RMB306 million in Sanya Company, holding 51.00% of its equity interests. According to the investment agreement and the articles of association of Sanya Company, the Group has joint control with another investor over Sanya Company, and therefore accounted for it as a joint venture. |
26
As at 31 December 2014, the Group owned the following associates and joint ventures:
Name |
Country of incorporation |
Percentage of equity interest held |
||||||
Associates CGB |
PRC | 20.00 | % | |||||
CLP&C |
PRC | 40.00 | % | |||||
Sino-Ocean |
Hong Kong, PRC | 29.46 | % | |||||
COFCO Futures |
PRC | 35.00 | % | |||||
Joint venture |
||||||||
10 Upper Bank Street SLP |
Jersey Island | 70.00 | % |
The following table illustrates the summarised financial information of the Groups associates and joint ventures as at 31 December 2015 and for the year ended 31 December 2015:
10 Upper | ||||||||||||||||||||||||||||
COFCO | Annoroad | Bank | Sanya | |||||||||||||||||||||||||
CGB | CLP&C | Sino-Ocean | Futures | Technology | Street SLP | Company | ||||||||||||||||||||||
RMB million | RMB million | RMB million | RMB million | RMB million | RMB million | RMB million | ||||||||||||||||||||||
Total assets |
1,836,587 | 65,634 | 148,185 | 8,598 | 337 | 8,503 | 600 | |||||||||||||||||||||
Total liabilities |
1,739,047 | 46,103 | 99,995 | 6,146 | 7 | 4,449 | | |||||||||||||||||||||
Total equity |
97,540 | 19,531 | 48,190 | 2,452 | 330 | 4,054 | 600 | |||||||||||||||||||||
Total equity attributable to equity holders of the associates and joint ventures |
97,540 | 19,531 | 41,231 | 2,452 | 330 | 4,054 | 600 | |||||||||||||||||||||
Total adjustments (i) |
| | 239 | | | (534 | ) | | ||||||||||||||||||||
Total equity attributable to equity holders of the associates and joint ventures after adjustments |
97,540 | 19,531 | 41,470 | 2,452 | 330 | 3,520 | 600 | |||||||||||||||||||||
Proportion of the Groups ownership |
20.00 | % | 40.00 | % | 29.998 | % | 35.00 | % | 16.67 | % | 70.00 | % | 51.00 | % | ||||||||||||||
Gross carrying value of the investments |
22,553 | 7,812 | 13,407 | 1,397 | 246 | 2,464 | 306 | |||||||||||||||||||||
Impairment |
| | (1,010 | ) | | | | | ||||||||||||||||||||
Net carrying value of the investments |
22,553 | 7,812 | 12,397 | 1,397 | 246 | 2,464 | 306 | |||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||
Total revenues |
54,735 | 46,829 | 31,226 | 390 | 100 | 432 | | |||||||||||||||||||||
Net profit/(loss) |
9,064 | 2,258 | 2,251 | 15 | (37 | ) | 496 | | ||||||||||||||||||||
Other comprehensive income |
1,028 | 379 | (80 | ) | (15 | ) | | 45 | | |||||||||||||||||||
Total comprehensive income |
10,092 | 2,637 | 2,171 | | (37 | ) | 541 | | ||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
27
The following table illustrates the summarised financial information of the Groups associates and joint ventures as at 31 December 2014 and for the year ended 31 December 2014:
10 Upper | ||||||||||||||||||||
COFCO | Bank | |||||||||||||||||||
CGB | CLP&C | Sino-Ocean | Futures | Street SLP | ||||||||||||||||
RMB million | RMB million | RMB million | RMB million | RMB million | ||||||||||||||||
Total assets |
1,648,056 | 52,769 | 132,212 | 9,784 | 8,199 | |||||||||||||||
Total liabilities |
1,560,607 | 35,876 | 87,829 | 7,245 | 4,450 | |||||||||||||||
Total equity |
87,449 | 16,893 | 44,383 | 2,539 | 3,749 | |||||||||||||||
Total equity attributable to equity holders of the associates and joint ventures |
87,449 | 16,893 | 40,491 | 2,539 | 3,749 | |||||||||||||||
Total adjustments (i) |
| | 984 | | (209 | ) | ||||||||||||||
Total equity attributable to equity holders of the associates and joint ventures after adjustments |
87,449 | 16,893 | 41,475 | 2,539 | 3,540 | |||||||||||||||
Proportion of the Groups ownership |
20.00 | % | 40.00 | % | 29.46 | % | 35.00 | % | 70.00 | % | ||||||||||
Gross carrying value of the investments |
20,535 | 6,757 | 13,186 | 1,434 | 2,478 | |||||||||||||||
Impairment |
| | | | | |||||||||||||||
Net carrying value of the investments |
20,535 | 6,757 | 13,186 | 1,434 | 2,478 | |||||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Total revenues |
44,644 | 36,522 | 40,411 | 3,306 | 241 | |||||||||||||||
Net profit |
12,037 | 1,407 | 4,606 | 84 | 142 | |||||||||||||||
Other comprehensive income |
2,120 | 318 | (19 | ) | 8 | (299 | ) | |||||||||||||
Total comprehensive income |
14,157 | 1,725 | 4,587 | 92 | (157 | ) | ||||||||||||||
|
|
|
|
|
|
|
|
|
|
The Group had no contingent liabilities or capital commitments with the associates and joint ventures as at 31 December 2015 and 31 December 2014.
(i) | Including adjustments for the difference of accounting policies, fair value and others. |
9 | PROFIT BEFORE INCOME TAX |
Profit before income tax is stated after charging/(crediting) the following:
For the year ended 31 December | ||||||||
2015 | 2014 | |||||||
RMB million | RMB million | |||||||
Employee salaries and welfare cost |
13,045 | 11,564 | ||||||
Housing benefits |
824 | 787 | ||||||
Contribution to the defined contribution pension plan |
1,678 | 1,553 | ||||||
Depreciation and amortisation |
2,036 | 2,124 | ||||||
Foreign exchange gains |
(812 | ) | (268 | ) | ||||
Auditors remuneration |
60 | 55 | ||||||
|
|
|
|
28
10 | TAXATION |
Deferred income tax assets and liabilities are offset when there is a legally enforceable right to offset current tax assets against current tax liabilities and when the deferred income tax relates to the same tax authority.
(a) | The amount of taxation charged to net profit represents: |
For the year ended 31 December | ||||||||
2015 | 2014 | |||||||
RMB million | RMB million | |||||||
Current taxation Enterprise income tax |
15,408 | 6,455 | ||||||
Deferred taxation |
(4,664 | ) | 1,433 | |||||
|
|
|
|
|||||
Taxation charges |
10,744 | 7,888 | ||||||
|
|
|
|
(b) | The reconciliation between the Groups effective tax rate and the statutory tax rate of 25% in the PRC (2014: 25%) is as follows: |
For the year ended 31 December | ||||||||
2015 | 2014 | |||||||
RMB million | RMB million | |||||||
Profit before income tax |
45,931 | 40,402 | ||||||
Tax computed at the statutory tax rate |
11,483 | 10,101 | ||||||
Non-taxable income (i) |
(3,324 | ) | (3,434 | ) | ||||
Expenses not deductible for tax purposes (i) |
2,655 | 1,190 | ||||||
Tax losses utilised from previous periods |
(41 | ) | | |||||
Unused tax losses |
1 | 19 | ||||||
Others |
(30 | ) | 12 | |||||
|
|
|
|
|||||
Income tax at the effective tax rate |
10,744 | 7,888 | ||||||
|
|
|
|
(i) | Non-taxable income mainly includes interest income from government bonds, and dividend income from applicable equity securities, etc. Expenses not deductible for tax purposes mainly include commission, brokerage, donation and other expenses that do not meet the criteria for deduction according to the relevant tax regulations. |
29
(c) | As at 31 December 2015 and 2014, deferred income tax was calculated in full on temporary differences under the liability method using a principal tax rate of 25%. The movements in deferred tax assets and liabilities during the year are as follows: |
Deferred tax assets/(liabilities)
Insurance | Investments | Others | Total | |||||||||||||
RMB million (i) |
RMB million (ii) |
RMB million (iii) |
RMB million | |||||||||||||
As at 1 January 2014 |
(11,627 | ) | 5,627 | 1,081 | (4,919 | ) | ||||||||||
(Charged)/credited to net profit |
552 | (1,940 | ) | (45 | ) | (1,433 | ) | |||||||||
(Charged)/credited to other comprehensive income |
||||||||||||||||
Available-for-sale securities |
| (15,805 | ) | | (15,805 | ) | ||||||||||
Portion of fair value changes on available-for-sale securities attributable to participating policyholders |
2,759 | | | 2,759 | ||||||||||||
Others |
| 23 | | 23 | ||||||||||||
|
|
|
|
|
|
|
|
|||||||||
As at 31 December 2014 |
(8,316 | ) | (12,095 | ) | 1,036 | (19,375 | ) | |||||||||
|
|
|
|
|
|
|
|
|||||||||
As at 1 January 2015 |
(8,316 | ) | (12,095 | ) | 1,036 | (19,375 | ) | |||||||||
(Charged)/credited to net profit |
3,673 | 843 | 148 | 4,664 | ||||||||||||
(Charged)/credited to other comprehensive income |
||||||||||||||||
Available-for-sale securities |
| (5,445 | ) | | (5,445 | ) | ||||||||||
Portion of fair value changes on available-for-sale securities attributable to participating policyholders |
3,192 | | | 3,192 | ||||||||||||
Others |
| 11 | | 11 | ||||||||||||
|
|
|
|
|
|
|
|
|||||||||
As at 31 December 2015 |
(1,451 | ) | (16,686 | ) | 1,184 | (16,953 | ) | |||||||||
|
|
|
|
|
|
|
|
(i) | The deferred tax arising from the insurance category is mainly related to the change of long-term insurance contract liabilities at 31 December 2008 as a result of the first time adoption of IFRSs in 2009 and the temporary differences of short-term insurance contract liabilities and policyholder dividend payables. |
(ii) | The deferred tax arising from the investments category is mainly related to the temporary differences of unrealised gains/(losses), which includes available-for-sale securities, securities at fair value through profit or loss, and others. |
(iii) | The deferred tax arising from the other categories is mainly related to the temporary differences of employee salaries and welfare cost payables. |
Unrecognised deductible tax losses of the Group amounted to RMB727 million as at 31 December 2015 (as at 31 December 2014: RMB879 million). Unrecognised deductible temporary differences of the Group amounted to RMB186 million as at 31 December 2015 (as at 31 December 2014: RMB166 million).
30
(d) | The analysis of deferred tax assets and deferred tax liabilities is as follows: |
As at 31 December 2015 RMB million |
As at 31 December 2014 RMB million |
|||||||
Deferred tax assets: |
||||||||
deferred tax assets to be recovered after 12 months |
9,528 | 4,219 | ||||||
deferred tax assets to be recovered within 12 months |
2,639 | 2,027 | ||||||
|
|
|
|
|||||
Subtotal |
12,167 | 6,246 | ||||||
|
|
|
|
|||||
Deferred tax liabilities: |
||||||||
deferred tax liabilities to be settled after 12 months |
(26,850 | ) | (24,130 | ) | ||||
deferred tax liabilities to be settled within 12 months |
(2,270 | ) | (1,491 | ) | ||||
|
|
|
|
|||||
Subtotal |
(29,120 | ) | (25,621 | ) | ||||
|
|
|
|
|||||
Net deferred tax liabilities |
(16,953 | ) | (19,375 | ) | ||||
|
|
|
|
11 | EARNINGS PER SHARE |
There is no difference between basic and diluted earnings per share. The basic and diluted earnings per share for the year ended 31 December 2015 are based on the net profit for the year attributable to ordinary equity holders of the Company and the weighted average number of 28,264,705,000 ordinary shares (2014: 28,264,705,000 ordinary shares).
12 | DIVIDENDS |
Pursuant to the shareholders approval at the Annual General Meeting on 28 May 2015, a final dividend of RMB0.40 per ordinary share totalling RMB11,306 million in respect of the year ended 31 December 2014 was declared and paid in 2015. The dividend has been recorded in the consolidated financial statements for the year ended 31 December 2015.
A distribution of RMB185 million to the holders of Core Tier 2 Capital Securities was approved by the management according to the authorization by the Board of Directors in 2015.
Pursuant to a resolution passed at the meeting of the Board of Directors on 23 March 2016, a final dividend of RMB0.42 per ordinary share totalling approximately RMB11,871 million for the year ended 31 December 2015 was proposed for shareholders approval at the forthcoming Annual General Meeting. The dividend has not been recorded in the consolidated financial statements for the year ended 31 December 2015.
31
CONSOLIDATED STATEMENT OF FINANCIAL POSITION
As at 31 December 2015
As at 31 December 2015 RMB million |
As at 31 December 2014 RMB million |
|||||||
ASSETS |
||||||||
Property, plant and equipment |
26,974 | 25,348 | ||||||
Investment properties |
1,237 | 1,283 | ||||||
Investments in associates and joint ventures |
47,175 | 44,390 | ||||||
Held-to-maturity securities |
504,075 | 517,283 | ||||||
Loans |
207,267 | 166,453 | ||||||
Term deposits |
562,622 | 690,156 | ||||||
Statutory deposits restricted |
6,333 | 6,153 | ||||||
Available-for-sale securities |
770,516 | 607,531 | ||||||
Securities at fair value through profit or loss |
137,990 | 53,052 | ||||||
Securities purchased under agreements to resell |
21,503 | 11,925 | ||||||
Accrued investment income |
49,552 | 44,350 | ||||||
Premiums receivable |
11,913 | 11,166 | ||||||
Reinsurance assets |
1,420 | 1,032 | ||||||
Other assets |
23,642 | 19,411 | ||||||
Cash and cash equivalents |
76,096 | 47,034 | ||||||
|
|
|
|
|||||
Total assets |
2,448,315 | 2,246,567 | ||||||
|
|
|
|
32
CONSOLIDATED STATEMENT OF FINANCIAL POSITION (Continued)
As at 31 December 2015
As at 31 December 2015 RMB million |
As at 31 2014 RMB million |
|||||||
LIABILITIES AND EQUITY |
||||||||
Liabilities |
||||||||
Insurance contracts |
1,715,985 | 1,603,446 | ||||||
Investment contracts |
84,106 | 72,275 | ||||||
Policyholder dividends payable |
107,774 | 74,745 | ||||||
Interest-bearing loans and borrowings |
2,643 | 2,623 | ||||||
Bonds payable |
67,994 | 67,989 | ||||||
Financial liabilities at fair value through profit or loss |
856 | 10,890 | ||||||
Securities sold under agreements to repurchase |
31,354 | 46,089 | ||||||
Annuity and other insurance balances payable |
30,092 | 25,617 | ||||||
Premiums received in advance |
32,266 | 15,850 | ||||||
Other liabilities |
26,514 | 20,062 | ||||||
Deferred tax liabilities |
16,953 | 19,375 | ||||||
Current income tax liabilities |
5,347 | 52 | ||||||
Statutory insurance fund |
217 | 223 | ||||||
|
|
|
|
|||||
Total liabilities |
2,122,101 | 1,959,236 | ||||||
|
|
|
|
|||||
Equity |
||||||||
Share capital |
28,265 | 28,265 | ||||||
Other equity instruments |
7,791 | | ||||||
Reserves |
163,381 | 145,919 | ||||||
Retained earnings |
123,055 | 109,937 | ||||||
|
|
|
|
|||||
Attributable to equity holders of the Company |
322,492 | 284,121 | ||||||
|
|
|
|
|||||
Non-controlling interests |
3,722 | 3,210 | ||||||
|
|
|
|
|||||
Total equity |
326,214 | 287,331 | ||||||
|
|
|
|
|||||
Total liabilities and equity |
2,448,315 | 2,246,567 | ||||||
|
|
|
|
33
CONSOLIDATED STATEMENT OF CHANGES IN EQUITY
For the year ended 31 December 2015
Attributable to equity holders of the Company |
Non- controlling interests |
Total | ||||||||||||||||||||||
Share capital |
Other equity instruments |
Reserves | Retained earnings |
|||||||||||||||||||||
RMB million | RMB million | RMB million | RMB million | RMB million | RMB million | |||||||||||||||||||
As at 1 January 2014 |
28,265 | | 97,029 | 95,037 | 2,254 | 222,585 | ||||||||||||||||||
Net profit |
| | | 32,211 | 303 | 32,514 | ||||||||||||||||||
Other comprehensive income |
| | 39,232 | | 52 | 39,284 | ||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||
Total comprehensive income |
| | 39,232 | 32,211 | 355 | 71,798 | ||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||
Transactions with owners |
||||||||||||||||||||||||
Capital paid in by non-controlling interests |
| | 826 | | 692 | 1,518 | ||||||||||||||||||
Appropriation to reserves |
| | 8,832 | (8,832 | ) | | | |||||||||||||||||
Dividends paid |
| | | (8,479 | ) | | (8,479 | ) | ||||||||||||||||
Dividends to non-controlling interests |
| | | | (91 | ) | (91 | ) | ||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||
Total transactions with owners |
| | 9,658 | (17,311 | ) | 601 | (7,052 | ) | ||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||
As at 31 December 2014 |
28,265 | | 145,919 | 109,937 | 3,210 | 287,331 | ||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||
As at 1 January 2015 |
28,265 | | 145,919 | 109,937 | 3,210 | 287,331 | ||||||||||||||||||
Net profit |
| | | 34,699 | 488 | 35,187 | ||||||||||||||||||
Other comprehensive income |
| | 7,076 | | 61 | 7,137 | ||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||
Total comprehensive income |
| | 7,076 | 34,699 | 549 | 42,324 | ||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||
Transactions with owners |
||||||||||||||||||||||||
Capital paid in by non-controlling interests |
| | | | 80 | 80 | ||||||||||||||||||
Capital paid in by other equity instruments holders |
| 7,791 | | | | 7,791 | ||||||||||||||||||
Appropriation to reserves |
| | 10,090 | (10,090 | ) | | | |||||||||||||||||
Dividends paid |
| | | (11,491 | ) | | (11,491 | ) | ||||||||||||||||
Dividends to non-controlling interests |
| | | | (117 | ) | (117 | ) | ||||||||||||||||
Others |
| | 296 | | | 296 | ||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||
Total transactions with owners |
| 7,791 | 10,386 | (21,581 | ) | (37 | ) | (3,441 | ) | |||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||
As at 31 December 2015 |
28,265 | 7,791 | 163,381 | 123,055 | 3,722 | 326,214 | ||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
34
CONSOLIDATED STATEMENT OF CASH FLOWS
For the year ended 31 December 2015
2015 | 2014 | |||||||
RMB million | RMB million | |||||||
CASH FLOWS FROM OPERATING ACTIVITIES |
||||||||
Profit before income tax |
45,931 | 40,402 | ||||||
Adjustments for: |
||||||||
Investment income |
(97,582 | ) | (93,548 | ) | ||||
Net realised and unrealised gains on financial assets |
(42,506 | ) | (12,928 | ) | ||||
Insurance contracts |
112,142 | 108,955 | ||||||
Depreciation and amortisation |
2,036 | 2,124 | ||||||
Foreign exchange gains |
(812 | ) | (268 | ) | ||||
Share of profit of associates and joint ventures, net |
(1,974 | ) | (3,911 | ) | ||||
Changes in operating assets and liabilities: |
||||||||
Securities at fair value through profit or loss |
(100,089 | ) | (13,698 | ) | ||||
Financial liabilities at fair value through profit or loss |
403 | 9,704 | ||||||
Receivables and payables |
70,482 | 41,330 | ||||||
Income tax paid |
(8,380 | ) | (1,923 | ) | ||||
Interest received securities at fair value through profit or loss |
1,225 | 1,902 | ||||||
Dividends received securities at fair value through profit or loss |
313 | 106 | ||||||
|
|
|
|
|||||
Net cash inflows/(outflows) from operating activities |
(18,811 | ) | 78,247 | |||||
|
|
|
|
|||||
CASH FLOWS FROM INVESTING ACTIVITIES |
||||||||
Disposals and maturities: |
||||||||
Disposals of debt securities |
11,546 | 21,242 | ||||||
Maturities of debt securities |
41,806 | 22,407 | ||||||
Disposals of equity securities |
400,451 | 285,647 | ||||||
Property, plant and equipment |
199 | 437 | ||||||
Disposal of subsidiaries |
3,875 | | ||||||
Purchases: |
||||||||
Debt securities |
(53,340 | ) | (115,808 | ) | ||||
Equity securities |
(522,787 | ) | (312,544 | ) | ||||
Property, plant and equipment |
(8,384 | ) | (5,048 | ) | ||||
Additional capital contribution to associates and joint ventures |
(766 | ) | (5,671 | ) | ||||
Decrease/(increase) in term deposits, net |
124,838 | (25,972 | ) | |||||
Decrease/(increase) in securities purchased under agreements to resell, net |
(9,602 | ) | (3,630 | ) | ||||
Interest received |
81,688 | 78,903 | ||||||
Dividends received |
8,828 | 4,258 | ||||||
Decrease/(increase) in policy loans, net |
(11,305 | ) | (13,478 | ) | ||||
|
|
|
|
|||||
Net cash inflows/(outflows) from investing activities |
67,047 | (69,257 | ) | |||||
|
|
|
|
35
CONSOLIDATED STATEMENT OF CASH FLOWS (Continued)
For the year ended 31 December 2015
2015 | 2014 | |||||||
RMB million | RMB million | |||||||
CASH FLOWS FROM FINANCING ACTIVITIES |
||||||||
Increase/(decrease) in securities sold under agreements to repurchase, net |
(13,757 | ) | 25,663 | |||||
Cash received from issuing other equity instruments |
7,791 | | ||||||
Cash received from borrowings |
| 2,881 | ||||||
Cash repaid to lenders |
| (10 | ) | |||||
Interest paid |
(4,471 | ) | (4,618 | ) | ||||
Dividends paid to equity holders of the Company |
(11,491 | ) | (8,479 | ) | ||||
Dividends paid to non-controlling interests |
(117 | ) | (91 | ) | ||||
Capital injected into subsidiaries by non-controlling interests |
2,630 | 1,358 | ||||||
|
|
|
|
|||||
Net cash inflows/(outflows) from financing activities |
(19,415 | ) | 16,704 | |||||
|
|
|
|
|||||
Foreign exchange gains on cash and cash equivalents |
241 | 10 | ||||||
Net increase in cash and cash equivalents |
29,062 | 25,704 | ||||||
|
|
|
|
|||||
Cash and cash equivalents Beginning of the year |
47,034 | 21,330 | ||||||
|
|
|
|
|||||
End of the year |
76,096 | 47,034 | ||||||
|
|
|
|
|||||
Analysis of balances of cash and cash equivalents |
||||||||
Cash at banks and in hand |
74,135 | 45,439 | ||||||
Short-term bank deposits |
1,961 | 1,595 | ||||||
|
|
|
|
36
SEGMENT INFORMATION
1 | Operating segments |
The Group operates in four operating segments:
(i) | Life insurance business (Life) |
Life insurance business relates primarily to the sale of life insurance policies, including those life insurance policies without significant insurance risk transferred.
(ii) | Health insurance business (Health) |
Health insurance business relates primarily to the sale of health insurance policies, including those health insurance policies without significant insurance risk transferred.
(iii) | Accident insurance business (Accident) |
Accident insurance business relates primarily to the sale of accident insurance policies.
(iv) | Other businesses (Others) |
Other businesses relate primarily to income and allocated cost of insurance agency business in respect of services to CLIC, net share of profit of associates and joint ventures, income and expenses of subsidiaries, and unallocated income and expenditure of the Group.
2 | Allocation basis of income and expenses |
Investment income, net realised gains on financial assets, net fair value gains/(losses) through profit or loss and foreign exchange gains/(losses) within other expenses are allocated among segments in proportion to the respective segments average liabilities of insurance contracts and investment contracts at the beginning and end of the year. Administrative expenses are allocated among segments in proportion to the unit cost of respective products in the different segments. Unallocated other income and other expenses are presented in the Others segment directly. Income tax is not allocated.
3 | Allocation basis of assets and liabilities |
Financial assets and securities sold under agreements to repurchase are allocated among segments in proportion to the respective segments average liabilities of insurance contracts and investment contracts at the beginning and end of the year. Insurance and investment contract liabilities are presented under the respective segments. The remaining assets and liabilities are not allocated.
37
For the year ended 31 December 2015 | ||||||||||||||||||||||||
Life | Health | Accident | Others | Elimination | Total | |||||||||||||||||||
RMB million | ||||||||||||||||||||||||
Revenues |
||||||||||||||||||||||||
Gross written premiums |
308,169 | 42,041 | 13,761 | | | 363,971 | ||||||||||||||||||
Term life |
3,476 | | | | | |||||||||||||||||||
Whole life |
28,119 | | | | | |||||||||||||||||||
Endowment |
177,871 | | | | | |||||||||||||||||||
Annuity |
98,703 | | | | | |||||||||||||||||||
Net premiums earned |
308,081 | 40,855 | 13,365 | | | 362,301 | ||||||||||||||||||
Investment income |
93,819 | 2,983 | 344 | 436 | | 97,582 | ||||||||||||||||||
Net realised gains/(losses) on financial assets |
31,259 | 992 | 115 | (69 | ) | | 32,297 | |||||||||||||||||
Net fair value gains /(losses) through profit or loss |
9,863 | 313 | 36 | (3 | ) | | 10,209 | |||||||||||||||||
Other income |
1,074 | 61 | | 5,006 | (1,081 | ) | 5,060 | |||||||||||||||||
Including: inter-segment revenue |
| | | 1,081 | (1,081 | ) | | |||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||
Segment revenues |
444,096 | 45,204 | 13,860 | 5,370 | (1,081 | ) | 507,449 | |||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||
Benefits, claims and expenses |
||||||||||||||||||||||||
Insurance benefits and claims expenses |
||||||||||||||||||||||||
Life insurance death and other benefits |
(219,944 | ) | (1,737 | ) | (20 | ) | | | (221,701 | ) | ||||||||||||||
Accident and health claims and claim adjustment expenses |
| (16,858 | ) | (4,151 | ) | | | (21,009 | ) | |||||||||||||||
Increase in insurance contract liabilities |
(93,668 | ) | (15,803 | ) | (38 | ) | | | (109,509 | ) | ||||||||||||||
Investment contract benefits |
(2,076 | ) | (188 | ) | | | | (2,264 | ) | |||||||||||||||
Policyholder dividends resulting from participation in profits |
(33,328 | ) | (163 | ) | | | | (33,491 | ) | |||||||||||||||
Underwriting and policy acquisition costs |
(24,921 | ) | (5,528 | ) | (3,813 | ) | (1,307 | ) | | (35,569 | ) | |||||||||||||
Finance costs |
(4,054 | ) | (129 | ) | (15 | ) | (122 | ) | | (4,320 | ) | |||||||||||||
Administrative expenses |
(18,293 | ) | (3,811 | ) | (3,136 | ) | (2,218 | ) | | (27,458 | ) | |||||||||||||
Other expenses |
(6,345 | ) | (327 | ) | (840 | ) | (997 | ) | 1,081 | (7,428 | ) | |||||||||||||
Including: inter-segment expenses |
(1,044 | ) | (33 | ) | (4 | ) | | 1,081 | | |||||||||||||||
Statutory insurance fund contribution |
(546 | ) | (103 | ) | (94 | ) | | | (743 | ) | ||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||
Segment benefits, claims and expenses |
(403,175 | ) | (44,647 | ) | (12,107 | ) | (4,644 | ) | 1,081 | (463,492 | ) | |||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||
Share of profit of associates and joint ventures, net |
| | | 1,974 | | 1,974 | ||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||
Segment results |
40,921 | 557 | 1,753 | 2,700 | | 45,931 | ||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||
Income tax |
(10,744 | ) | ||||||||||||||||||||||
|
|
|||||||||||||||||||||||
Net profit |
35,187 | |||||||||||||||||||||||
|
|
|||||||||||||||||||||||
Attributable to |
||||||||||||||||||||||||
Equity holders of the Company |
34,699 | |||||||||||||||||||||||
Non-controlling interests |
488 | |||||||||||||||||||||||
Other comprehensive income attributable to equity holders of the Company |
6,359 | 202 | 23 | 492 | | 7,076 | ||||||||||||||||||
Depreciation and amortisation |
1,388 | 263 | 240 | 145 | | 2,036 |
38
As at 31 December 2015 | ||||||||||||||||||||||||
Life | Health | Accident | Others | Elimination | Total | |||||||||||||||||||
RMB million | ||||||||||||||||||||||||
Assets |
||||||||||||||||||||||||
Financial assets (including cash and cash equivalents) |
2,243,403 | 69,565 | 7,968 | 14,900 | | 2,335,836 | ||||||||||||||||||
Others |
7,904 | 4,917 | 475 | 47,175 | | 60,471 | ||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||
Segment assets |
2,251,307 | 74,482 | 8,443 | 62,075 | | 2,396,307 | ||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||
Unallocated |
||||||||||||||||||||||||
Property, plant and equipment |
26,974 | |||||||||||||||||||||||
Others |
25,034 | |||||||||||||||||||||||
|
|
|||||||||||||||||||||||
Total |
2,448,315 | |||||||||||||||||||||||
|
|
|||||||||||||||||||||||
Liabilities |
||||||||||||||||||||||||
Insurance contracts |
1,652,469 | 57,024 | 6,492 | | | 1,715,985 | ||||||||||||||||||
Investment contracts |
74,046 | 10,060 | | | | 84,106 | ||||||||||||||||||
Securities sold under agreements to repurchase |
29,329 | 931 | 108 | 986 | | 31,354 | ||||||||||||||||||
Others |
94,589 | 3,278 | 401 | 3,499 | | 101,767 | ||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||
Segment liabilities |
1,850,433 | 71,293 | 7,001 | 4,485 | | 1,933,212 | ||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||
Unallocated |
||||||||||||||||||||||||
Others |
188,889 | |||||||||||||||||||||||
|
|
|||||||||||||||||||||||
Total |
2,122,101 | |||||||||||||||||||||||
|
|
39
For the year ended 31 December 2014 | ||||||||||||||||||||||||
Life | Health | Accident | Others | Elimination | Total | |||||||||||||||||||
RMB million | ||||||||||||||||||||||||
Revenues |
||||||||||||||||||||||||
Gross written premiums |
285,619 | 33,192 | 12,199 | | | 331,010 | ||||||||||||||||||
Term life |
2,871 | | | | | |||||||||||||||||||
Whole life |
29,767 | | | | | |||||||||||||||||||
Endowment |
217,662 | | | | | |||||||||||||||||||
Annuity |
35,319 | | | | | |||||||||||||||||||
Net premiums earned |
285,574 | 32,624 | 11,907 | | | 330,105 | ||||||||||||||||||
Investment income |
89,814 | 2,236 | 315 | 1,183 | | 93,548 | ||||||||||||||||||
Net realised gains/(losses) on financial assets |
6,970 | 174 | 24 | (48 | ) | | 7,120 | |||||||||||||||||
Net fair value gains/(losses) through profit or loss |
6,179 | 154 | 22 | (547 | ) | | 5,808 | |||||||||||||||||
Other income |
898 | 67 | | 4,148 | (928 | ) | 4,185 | |||||||||||||||||
Including: inter-segment revenue |
| | | 928 | (928 | ) | | |||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||
Segment revenues |
389,435 | 35,255 | 12,268 | 4,736 | (928 | ) | 440,766 | |||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||
Benefits, claims and expenses |
||||||||||||||||||||||||
Insurance benefits and claims expenses |
||||||||||||||||||||||||
Life insurance death and other benefits |
(191,291 | ) | (1,355 | ) | (13 | ) | | | (192,659 | ) | ||||||||||||||
Accident and health claims and claim adjustment expenses |
| (12,883 | ) | (3,869 | ) | | | (16,752 | ) | |||||||||||||||
Increase in insurance contract liabilities |
(97,577 | ) | (8,196 | ) | (110 | ) | | | (105,883 | ) | ||||||||||||||
Investment contract benefits |
(1,806 | ) | (152 | ) | | | | (1,958 | ) | |||||||||||||||
Policyholder dividends resulting from participation in profits |
(24,742 | ) | (124 | ) | | | | (24,866 | ) | |||||||||||||||
Underwriting and policy acquisition costs |
(18,126 | ) | (4,770 | ) | (3,354 | ) | (897 | ) | | (27,147 | ) | |||||||||||||
Finance costs |
(4,451 | ) | (111 | ) | (16 | ) | (148 | ) | | (4,726 | ) | |||||||||||||
Administrative expenses |
(16,677 | ) | (4,092 | ) | (2,576 | ) | (2,087 | ) | | (25,432 | ) | |||||||||||||
Other expenses |
(3,608 | ) | (204 | ) | (705 | ) | (562 | ) | 928 | (4,151 | ) | |||||||||||||
Including: inter-segment expenses |
(903 | ) | (22 | ) | (3 | ) | | 928 | | |||||||||||||||
Statutory insurance fund contribution |
(506 | ) | (116 | ) | (79 | ) | | | (701 | ) | ||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||
Segment benefits, claims and expenses |
(358,784 | ) | (32,003 | ) | (10,722 | ) | (3,694 | ) | 928 | (404,275 | ) | |||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||
Share of profit of associates and joint ventures, net |
| | | 3,911 | | 3,911 | ||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||
Segment results |
30,651 | 3,252 | 1,546 | 4,953 | | 40,402 | ||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||
Income tax |
(7,888 | ) | ||||||||||||||||||||||
|
|
|||||||||||||||||||||||
Net profit |
32,514 | |||||||||||||||||||||||
|
|
|||||||||||||||||||||||
Attributable to |
||||||||||||||||||||||||
Equity holders of the Company |
32,211 | |||||||||||||||||||||||
Non-controlling interests |
303 | |||||||||||||||||||||||
Other comprehensive income attributable to equity holders of the Company |
38,270 | 951 | 134 | (123 | ) | | 39,232 | |||||||||||||||||
Depreciation and amortisation |
1,427 | 324 | 221 | 152 | | 2,124 |
40
As at 31 December 2014 | ||||||||||||||||||||||||
Life | Health | Accident | Others | Elimination | Total | |||||||||||||||||||
RMB million | ||||||||||||||||||||||||
Assets |
||||||||||||||||||||||||
Financial assets (including cash and cash equivalents) |
2,059,641 | 50,013 | 6,961 | 27,421 | | 2,144,036 | ||||||||||||||||||
Others |
7,881 | 3,985 | 312 | 44,390 | | 56,568 | ||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||
Segment assets |
2,067,522 | 53,998 | 7,273 | 71,811 | | 2,200,604 | ||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||
Unallocated |
||||||||||||||||||||||||
Property, plant and equipment |
25,348 | |||||||||||||||||||||||
Others |
20,615 | |||||||||||||||||||||||
|
|
|||||||||||||||||||||||
Total |
2,246,567 | |||||||||||||||||||||||
|
|
|||||||||||||||||||||||
Liabilities |
||||||||||||||||||||||||
Insurance contracts |
1,558,714 | 38,872 | 5,860 | | | 1,603,446 | ||||||||||||||||||
Investment contracts |
63,710 | 8,565 | | | | 72,275 | ||||||||||||||||||
Securities sold under agreements to repurchase |
43,310 | 1,076 | 152 | 1,551 | | 46,089 | ||||||||||||||||||
Others |
90,703 | 2,732 | 372 | 13,513 | | 107,320 | ||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||
Segment liabilities |
1,756,437 | 51,245 | 6,384 | 15,064 | | 1,829,130 | ||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||
Unallocated |
||||||||||||||||||||||||
Others |
130,106 | |||||||||||||||||||||||
|
|
|||||||||||||||||||||||
Total |
1,959,236 | |||||||||||||||||||||||
|
|
41
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
The principal accounting policies applied in the preparation of these consolidated financial statements are set out below. These policies have been consistently applied to all the years presented, unless otherwise stated.
Basis of preparation
The Group has prepared these consolidated financial statements in accordance with International Financial Reporting Standards (IFRSs), amendments to IFRSs and interpretations issued by the International Accounting Standards Board (IASB). These consolidated financial statements also comply with the applicable disclosure provisions of the Rules Governing the Listing of Securities on The Stock Exchange of Hong Kong Limited (the Listing Rules) and the applicable disclosure requirements of the Hong Kong Companies Ordinance. The Group has prepared the consolidated financial statements under the historical cost convention, except for financial assets and liabilities at fair value through profit or loss, available-for-sale securities, insurance contract liabilities and certain property, plant and equipment at deemed cost as part of the Restructuring process. The preparation of financial statements in conformity with IFRSs requires the use of certain critical accounting estimates. It also requires management to exercise its judgement in the process of applying the Groups accounting policies.
New accounting standards and amendments adopted by the Group for the first time for the financial year beginning on 1 January 2015
Standards
Annual Improvements 2010-2012 Cycle
Annual Improvements 2011-2013 Cycle
The Annual Improvements 2010-2012 Cycle issued in January 2014 sets out amendments to a number of IFRSs and International Accounting Standards (IASs). Details of the main amendments that are effective for the current year are as follows:
IFRS 8 Amendments Operating Segments
The amendments to IFRS 8 clarify that an entity must disclose the judgements made by management in applying the aggregation criteria in IFRS 8, including a brief description of operating segments that have been aggregated and the economic characteristics used to assess whether the segments are similar. The amendments also clarify that the reconciliation of segment assets to total assets is only required to be disclosed if the reconciliation is reported to the chief operating decision maker. The amendments have had no impact on the Groups consolidated financial statements.
42
IAS 24 Amendments Related Party Disclosures
The amendments to IAS 24 clarify that a management entity (an entity that provides key management personnel services) is a related party subject to the related party disclosures. In addition, an entity that uses a management entity is required to disclose the expenses incurred for management services. These amendments are not relevant for the Group as it does not receive any management services from other entities.
The Annual Improvements 2011-2013 Cycle issued in January 2014 sets out amendments to a number of IFRSs and IASs. Details of the main amendments that are effective for the current year are as follows:
IFRS 3 Amendments Business Combinations
The amendments to IFRS 3 clarify that joint arrangements, not just joint ventures, are outside the scope of IFRS 3. This scope exception applies only to the accounting in the financial statements of the joint arrangement itself. The amendments have had no impact on the Group as the Company is not a joint arrangement.
IFRS 13 Amendments Fair Value Measurement
The amendments to IFRS 13 clarify that the portfolio exception in IFRS 13 can be applied not only to financial assets and financial liabilities, but also to other contracts within the scope of IFRS 9 Financial Instruments and IAS 39 Recognition and Measurement. The amendments have had no impact on the Groups consolidated financial statements.
In addition, the Group has adopted the amendments to the Listing Rules relating to the disclosure of financial information with reference to the Hong Kong Companies Ordinance (Cap. 622) during the current financial year. The main impact to the financial statements is on the presentation and disclosure of certain information in the financial statements.
43
New accounting standards and amendments that are not yet effective and have not been early adopted by the Group for the financial year beginning on 1 January 2015
Standards/Amendments |
Content |
Effective for annual period beginning on or after | ||
IAS 27 Amendments | Equity Method in Separate Financial Statements |
1 January 2016 | ||
IFRS 10 and IAS 28 Amendments | Sale or Contribution of Assets between an Investor and its Associate or Joint Venture |
1 January 2016 | ||
IFRS 11 Amendments | Accounting for Acquisitions of Interests in Joint Operations |
1 January 2016 | ||
IFRS 10, IFRS 12 and IAS 28 Amendments | Investment Entities: Applying the Consolidation Exception |
1 January 2016 | ||
IAS 7 Amendments | Statement of Cash Flows |
1 January 2017 | ||
IFRS 9 | Financial Instruments |
1 January 2018 | ||
IFRS 15 | Revenue from Contracts with Customers |
1 January 2018 | ||
IFRS 16 | Leases |
1 January 2019 |
IAS 27 Amendments Equity Method in Separate Financial Statements
The amendments to IAS 27 will allow entities to use the equity method to account for investments in subsidiaries, joint ventures and associates in their separate financial statements. The amendments are effective for annual periods beginning on or after 1 January 2016, with early adoption permitted. The amendments are not expected to have any impact on the Groups consolidated financial statements since the Group has no intention to apply the equity method in the separate financial statements.
IFRS 10 and IAS 28 Amendments Sale or Contribution of Assets between an Investor and its Associate or Joint Venture
These amendments eliminate the inconsistency between the requirements in IFRS 10 and those in IAS 28 Investments in Associates and Joint Ventures with regard to dealing with the contribution or sale of assets between an investor and its associate or joint venture. These amendments are effective for annual periods beginning on or after 1 January 2016, with early adoption permitted. The amendments are not expected to have any material impact on the Groups consolidated financial statements.
44
IFRS 11 Amendments Accounting for Acquisitions of Interests in Joint Operations
The amendments to IFRS 11 require that a joint operator accounting for the acquisition of an interest in a joint operation, in which the activity of the joint operation constitutes a business, must apply the relevant IFRS 3 principles for business combinations accounting. The amendments also clarify that a previously held interest in a joint operation is not remeasured on the acquisition of an additional interest in the same joint operation while joint control is retained. The amendments are effective for annual periods beginning on or after 1 January 2016, with early adoption permitted. It is not expected that the amendments would be relevant to the Group, since the Group has no joint operation as at 31 December 2015.
IFRS 10, IFRS 12 and IAS 28 Amendments Investment Entities: Applying the Consolidation Exception
Amendments to IFRS 10 clarify that the exemption from presenting consolidated financial statements applies to a parent entity that is a subsidiary of an investment entity, when the investment entity measures all of its subsidiaries at fair value. The amendments to IFRS 10 also clarify that only a subsidiary that is not an investment entity itself and provides support services to the investment entity is consolidated. All other subsidiaries of an investment entity are measured at fair value. Consequential amendments were made to IFRS 12 to require an investment entity that prepares financial statements in which all of its subsidiaries are measured at fair value through profit or loss in accordance with IFRS 9 to present the disclosures in respect of investment entities in accordance with IFRS 12. IAS 28 was also amended to allow an investor that is not itself an investment entity, and has an interest in an investment entity associate or joint venture, to retain the fair value measurement applied by the investment entity associate or joint venture to the interest in its subsidiaries. The amendments are not expected to have any material impact on the Groups consolidated financial statements as the Company is not an investment entity as defined in IFRS 10.
IAS 7 Amendments Statement of Cash Flows
In January 2016, the IASB published amendments to IAS 7 Statement of Cash Flows. The amendments require an entity to provide disclosures that enable users of financial statements to evaluate changes in liabilities arising from financing activities, including both changes arising from cash flows and non-cash changes. The amendments should be applied for annual periods beginning on or after 1 January 2017, early application is permitted. When an entity first applies the amendments, it is not required to provide comparative information for preceding periods.
45
IFRS 9 Financial Instruments
In July 2014, the IASB issued the final version of IFRS 9 Financial Instruments which reflects all phases of the financial instruments project and replaces IAS 39 Financial Instruments: Recognition and Measurement and all previous versions of IFRS 9. The standard introduces new requirements for classification and measurement, impairment, and hedge accounting. IFRS 9 is effective for annual periods beginning on or after 1 January 2018, with early adoption permitted. The Group is currently assessing the impact on the Groups consolidated financial statements.
IFRS 15 Revenue from Contracts with Customers
IFRS 15 establishes a new five-step model that will apply to revenue arising from contracts with customers. Under IFRS 15, revenue is recognised at an amount that reflects the consideration to which an entity expects to be entitled in exchange for transferring goods or services to a customer. The principles in IFRS 15 provide a more structured approach to measuring and recognising revenue. In September 2015, the IASB issued amendments to IFRS 15 regarding a one-year deferral of the mandatory effective date of IFRS 15 to 1 January 2018. IFRS 15 is not applied to the insurance contracts and financial instruments, which are the main source of the Groups revenue. The Group is currently assessing the impact on the Groups consolidated financial statements.
IFRS 16 Leases
IFRS 16 supersedes IAS 17 Leases. It requires lessees to recognise leases as assets and liabilities on their balance sheets, with certain exemptions. The lessor accounting is substantially unchanged. IFRS 16 will be effective for annual periods beginning on or after 1 January 2019. Early application is permitted, provided that IFRS 15 Revenue from Contracts with Customers is applied. The Group is currently assessing the impact on the Groups consolidated financial statements.
In addition, the Annual Improvements 2012-2014 Cycle issued in September 2014 sets out amendments to other standards. These annual improvements were established to make non-urgent but necessary amendments to IFRSs. No material changes to the accounting policies of the Group are expected as a result of these annual improvements.
46
EMBEDDED VALUE
Assumptions
Economic assumptions:
The calculations are based upon assumed corporate tax rate of 25% for all years. The investment returns are assumed to be grading from 5.1% to 5.5% by 0.1% every year (remaining level thereafter). 12% grading to 16% by 1% every year (remaining level thereafter) of the investment return is assumed to be exempt from income tax. These investment return and tax exempt assumptions are based on the Companys strategic asset mix and expected future returns. The risk-adjusted discount rate used is 11%.
Other operating assumptions such as mortality, morbidity, lapses and expenses are based on the Companys recent operating experience and expected future outlook.
SUMMARY OF RESULTS
The embedded value as at 31 December 2015 and the value of one years sales for the 12 months to 31 December 2015, the corresponding results as at 31 December 2014 are shown below:
Table 1
Components of Embedded Value and Value of One Years Sales | RMB million | |||||||||
ITEM | 31 December 2015 |
31 December 2014 |
||||||||
A | Adjusted Net Worth | 268,729 | 194,236 | |||||||
B | Value of In-Force Business before Cost of Solvency Margin | 335,500 | 300,712 | |||||||
C | Cost of Solvency Margin | (43,951 | ) | (40,042 | ) | |||||
D | Value of In-Force Business after Cost of Solvency Margin (B + C) | 291,549 | 260,670 | |||||||
E | Embedded Value (A + D) | 560,277 | 454,906 | |||||||
F | Value of One Years Sales before Cost of Solvency Margin | 35,684 | 26,633 | |||||||
G | Cost of Solvency Margin | (4,155 | ) | (3,380 | ) | |||||
H | Value of One Years Sales after Cost of Solvency Margin (F + G) | 31,528 | 23,253 |
Notes: |
1) Numbers may not be additive due to rounding. | |
2) Taxable incomes in embedded value and the value of one years sales are based on earnings calculated using solvency reserves. |
47
VALUE OF ONE YEARS SALES BY CHANNEL
The value of one years sales by channel is shown below:
Table 2
Value of One Years Sales by Channel | RMB million | |||||||
31 December 2015 |
31 December 2014 |
|||||||
Channel |
||||||||
Exclusive Individual Agent Channel |
28,851 | 21,740 | ||||||
Group Insurance Channel |
371 | 464 | ||||||
Bancassurance Channel |
2,306 | 1,048 | ||||||
Total |
31,528 | 23,253 |
Notes: |
1) Numbers may not be additive due to rounding. | |
2) Taxable income is based on earnings calculated using solvency reserves. |
MOVEMENT ANALYSIS
The following analysis tracks the movement of the embedded value from the start to the end of the Reporting Period.
Table 3
Analysis of Embedded Value Movement in 2015 | RMB million | |||||
ITEM |
||||||
A | Embedded Value at Start of Year | 454,906 | ||||
B | Expected Return on Embedded Value | 44,956 | ||||
C | Value of New Business in the Period | 31,528 | ||||
D | Operating Experience Variance | 2,685 | ||||
E | Investment Experience Variance | 20,591 | ||||
F | Methodology, Model and Assumption Changes | (5,602) | ||||
G | Market Value and Other Adjustments | 14,199 | ||||
H | Exchange Gains or Losses | 745 | ||||
I | Shareholder Dividend Distribution and Capital Injection | (3,699) | ||||
J | Other | (34) | ||||
K |
Embedded Value as at 31 December 2015 (sum A through J) | 560,277 |
Notes: |
1) Numbers may not be additive due to rounding. | |
2) Items B through J are explained below: |
B | Reflects expected impact of covered business, and the expected return on investments supporting the 2015 opening net worth. |
C | Value of new business sales in 2015. |
48
D | Reflects the difference between actual operating experience in 2015 (including mortality, morbidity, lapse, and expenses etc.) and the assumptions. |
E | Compares actual with expected investment returns during 2015. |
F | Reflects the effect of projection method, model enhancements and assumption changes. |
G | Change in the market value adjustment from the beginning of year 2015 to 31 December 2015 and other related adjustments. |
H | Reflects the gains or losses due to changes in exchange rate. |
I | Reflects dividends distributed to shareholders and issuance of Core Tier 2 Capital Securities during 2015. |
J | Other miscellaneous items. |
SENSITIVITY RESULTS
Sensitivity testing was performed using a range of alternative assumptions. In each of the sensitivity tests, only the assumption referred to was changed, with all other assumptions remaining unchanged. The results are summarized below:
Table 4
Sensitivity Results | RMB million | |||||||||
VALUE OF IN-FORCE OF SOLVENCY MARGIN |
VALUE OF ONE YEARS OF SOLVENCY MARGIN |
|||||||||
Base case scenario |
291,549 | 31,528 | ||||||||
1. |
Risk discount rate of 11.5% |
278,043 | 29,953 | |||||||
2. |
Risk discount rate of 10.5% |
306,029 | 33,222 | |||||||
3. |
10% increase in investment return |
338,279 | 37,274 | |||||||
4. |
10% decrease in investment return |
245,077 | 25,789 | |||||||
5. |
10% increase in expenses |
288,643 | 29,372 | |||||||
6. |
10% decrease in expenses |
294,454 | 33,685 | |||||||
7. |
10% increase in mortality rate for non-annuity products and 10% decrease in mortality rate for annuity products |
289,720 | 31,388 | |||||||
8. |
10% decrease in mortality rate for non-annuity products and 10% increase in mortality rate for annuity products |
293,398 | 31,669 | |||||||
9. |
10% increase in lapse rates |
290,806 | 30,959 | |||||||
10. |
10% decrease in lapse rates |
292,199 | 32,029 | |||||||
11. |
10% increase in morbidity rates |
288,533 | 31,355 | |||||||
12. |
10% decrease in morbidity rates |
294,595 | 31,704 | |||||||
13. |
10% increase in claim ratio of short term business |
291,150 | 30,662 | |||||||
14. |
10% decrease in claim ratio of short term business |
291,947 | 32,395 | |||||||
15. |
Solvency margin at 150% of statutory minimum |
269,973 | 29,388 | |||||||
16. |
Using 2014 EV assumptions |
297,864 | 32,291 | |||||||
17. |
Taxable income based on the accounting profit in accordance to the Provisions on the Accounting Treatment Related to Insurance Contracts under one possible scenario |
292,818 | 31,338 |
Note: | Taxable income is based on earnings calculated using solvency reserves for Scenarios 1 to 16. |
49
CORPORATE GOVERNANCE
The Company has applied the principles of the Corporate Governance Code as set out in Appendix 14 to the Rules Governing the Listing of Securities on the Stock Exchange of Hong Kong Limited, and has complied with all code provisions of the Corporate Governance Code during the Reporting Period.
PURCHASE, SALES OR REDEMPTION OF THE COMPANYS SECURITIES
During the Reporting Period, save as disclosed below, the Company and its subsidiaries did not purchase, sell or redeem any of the Companys listed securities.
The Company issued US$1,280 million Core Tier 2 Capital Securities at an initial distribution rate of 4.00% by way of debt issues to professional investors only. The securities (Stock Code: 5540) were permitted for listing and trading on the Stock Exchange of Hong Kong Limited on 6 July 2015.
ELIGIBILITY FOR ATTENDING THE ANNUAL GENERAL MEETING AND CLOSURE OF REGISTER OF MEMBERS FOR H SHARES
The H Share register of members of the Company will be closed for the purpose of determining H Share shareholders entitlement to attend the Annual General Meeting, from Saturday, 30 April 2016 to Monday, 30 May 2016 (both days inclusive), during which period no transfer of H Shares will be registered. In order to attend the Annual General Meeting, H Share shareholders should ensure that all transfer documents, accompanied by the relevant share certificates, are lodged with the Companys H Share registrar, Computershare Hong Kong Investor Services Limited, at Shops 1712-1716, 17th Floor, Hopewell Centre, 183 Queens Road East, Wanchai, Hong Kong, not later than 4:30 p.m. on Friday, 29 April 2016.
RECOMMENDATION OF FINAL DIVIDEND, WITHHOLDING AND PAYMENT OF INCOME TAX AND CLOSURE OF REGISTER OF MEMBERS FOR H SHARES
The Board of Directors has recommended a final dividend of RMB0.42 per share (inclusive of tax), amounting to a total of approximately RMB11,871 million, subject to the approval of shareholders at the forthcoming Annual General Meeting scheduled on Monday, 30 May 2016. If approved, the final dividend is expected to be paid on Friday, 5 August 2016 to the H Share shareholders whose names appear on the H Share register of members of the Company on Thursday, 16 June 2016.
The H Share register of members of the Company will be closed from Friday, 10 June 2016 to Thursday, 16 June 2016 (both days inclusive), during which period no transfer of shares will be registered. In order to be entitled to the dividend, H Share shareholders should ensure that all transfer documents, accompanied by the relevant share certificates, are lodged with the Companys H Share registrar, Computershare Hong Kong Investor Services Limited, at Shops 1712-1716, 17th Floor, Hopewell Centre, 183 Queens Road East, Wanchai, Hong Kong, not later than 4:30 p.m. on Wednesday, 8 June 2016.
50
According to the Enterprise Income Tax Law of the Peoples Republic of China and its implementation regulations which came into effect on 1 January 2008 and other relevant rules and regulations, the Company is required to withhold and pay enterprise income tax at the rate of 10% before distributing the 2015 final dividend to non-resident enterprise shareholders as appearing on the H Share register of members of the Company. Any shares registered in the name of non-individual registered shareholders, including HKSCC Nominees Limited, other nominees, trustees or other groups and organizations, will be treated as being held by non-resident enterprise shareholders and therefore will be subject to the withholding of the enterprise income tax.
Pursuant to the Individual Income Tax Law of Peoples Republic of China and its implementation regulations and other relevant rules and regulations, the Company is required to withhold and pay individual income tax before distributing the 2015 final dividend to individual shareholders as appearing on the H Share register of members of the Company (the Individual H Shareholders). However, the Individual H Shareholders may be entitled to certain tax preferential treatments pursuant to the tax treaties between the PRC and the countries (regions) in which the Individual H Shareholders are domiciled and the tax arrangements between Mainland China and Hong Kong (Macau). In this regard, the Company will implement the following arrangements in relation to the withholding and payment of individual income tax for the Individual H Shareholders:
| For Individual H Shareholders who are Hong Kong or Macau residents or whose country (region) of domicile is a country (region) which has entered into a tax treaty with the PRC stipulating a tax rate of 10%, the Company will withhold and pay individual income tax at the rate of 10% on behalf of the Individual H Shareholders in the distribution of final dividend; |
| For Individual H Shareholders whose country (region) of domicile is a country (region) which has entered into a tax treaty with the PRC stipulating a tax rate of less than 10%, the Company will temporarily withhold and pay individual income tax at the rate of 10% on behalf of the Individual H Shareholders in the distribution of final dividend; |
| For Individual H Shareholders whose country (region) of domicile is a country (region) which has entered into a tax treaty with the PRC stipulating a tax rate of more than 10% but less than 20%, the Company will withhold and pay individual income tax at the effective tax rate stipulated in the relevant tax treaty in the distribution of final dividend; |
| For Individual H Shareholders whose country (region) of domicile is a country (region) which has entered into a tax treaty with the PRC stipulating a tax rate of 20%, or a country (region) which has not entered into any tax treaties with the PRC, or under any other circumstances, the Company will withhold and pay individual income tax at the rate of 20% on behalf of the Individual H Shareholders in the distribution of final dividend. |
51
If Individual H Shareholders consider that the tax rate adopted by the Company for the withholding and payment of individual income tax on their behalf is not the same as the tax rate stipulated in any tax treaties between the PRC and the countries (regions) in which they are domiciled, please submit promptly to the H Share registrar of the Company, Computershare Hong Kong Investor Services Limited, a letter of entrustment and all application materials showing that they are residents of a country (region) which has entered into a tax treaty with the PRC. The Company will then submit the above documents to competent tax authorities who will proceed with the subsequent tax related arrangements.
As to the A Share shareholders, it is expected that the Company will complete the distribution of the 2015 final dividend by Monday, 20 June 2016. The Company will announce separately the details of the arrangement regarding the distribution of the 2015 final dividend to its A Share shareholders.
For Hong Kong investors (including enterprises and individuals) investing in the Companys A Shares via the Shanghai Stock Connect Program, their dividends will be distributed in RMB by the Company through the Shanghai Branch of China Securities Depository and Clearing Corporation Limited to the account of the nominee holding such A Shares. The Company will withhold and pay income tax at the rate of 10% on behalf of those investors. For investors via the Shanghai Stock Connect Program who are tax residents of other countries and whose country of domicile is a country which has entered into a tax treaty with the PRC stipulating a dividend tax rate of less than 10%, those enterprises or individuals may, or may entrust a withholding agent to, apply to the competent tax authorities for the entitlement of the rate under such tax treaty. Upon approval by the tax authorities, the paid amount in excess of the tax payable based on the tax rate according to such tax treaty will be refunded. The record date, the dividend distribution date and other arrangements for investors via the Shanghai Stock Connect Program will be the same as those for the Companys A Share shareholders.
For Mainland investors (including enterprises and individuals) investing in the Companys H Shares via the Hong Kong Stock Connect Program, the Shanghai Branch of China Securities Depository and Clearing Corporation Limited, as the nominee of the holders of H Shares for investors via the Hong Kong Stock Connect Program, will receive the dividends distributed by the Company and distribute such dividends to the relevant investors of H Shares through its depositary and clearing system. The final dividend to be distributed to the investors of H Shares via the Hong Kong Stock Connect Program will be paid in RMB. If approved at the Annual General Meeting, the final dividend is expected to be paid on Wednesday, 10 August 2016 to the investors of H Shares via the Hong Kong Stock Connect Program. Pursuant to the Notice on Relevant Taxation Policies Concerning the Pilot Inter-connected Mechanism for Trading on the Shanghai Stock Market and the Hong Kong Stock Market (Cai Shui [2014] No. 81) promulgated on 17 November 2014:
52
| For Mainland individual investors who invest in the H Shares of the Company via the Hong Kong Stock Connect Program, the Company will withhold individual income tax at the rate of 20% in the distribution of final dividend. Individual investors may, by producing valid tax payment proofs, apply to the competent tax authority of China Securities Depository and Clearing Corporation Limited for tax refund relating to the withholding tax already paid abroad. For Mainland securities investment funds that invest in the H Shares of the Company via the Hong Kong Stock Connect Program, the Company will withhold individual income tax in the distribution of final dividend pursuant to the foregoing provisions; |
| For Mainland enterprise investors that invest in the H Shares of the Company via the Hong Kong Stock Connect Program, the Company will not withhold the income tax in the distribution of final dividend and the Mainland enterprise investors shall pay the tax on their own. |
REVIEW OF ANNUAL RESULTS
The Audit Committee of the Company has reviewed the annual results of the Company for the year ended 31 December 2015. The 2015 consolidated financial statements prepared in accordance with the International Financial Reporting Standards have been audited by Ernst & Young based on the International Standards on Auditing, and Ernst & Young has issued standard unqualified opinions on the 2015 consolidated financial statements.
PUBLICATION OF ANNUAL REPORT
The Companys annual report will be published on the Companys website (http://www.e-chinalife.com) and the HKExnews website of Hong Kong Exchanges and Clearing Limited (http://www.hkexnews.hk) in due course.
This announcement is published in both English and Chinese. Should there be any inconsistency between the Chinese and English versions, the Chinese version shall prevail.
As at the date of this announcement, the Board of Directors of the Company comprises:
Executive Directors: |
Yang Mingsheng, Lin Dairen, Xu Hengping, Xu Haifeng | |
Non-executive Directors: |
Miao Jianmin, Zhang Xiangxian, Wang Sidong, Liu Jiade | |
Independent Non-executive Directors: |
Anthony Francis Neoh, Chang Tso Tung Stephen, | |
Robinson Drake Pike, Tang Xin |
By Order of the Board |
CHINA LIFE INSURANCE COMPANY LIMITED |
Yang Mingsheng |
Chairman |
Beijing, China
23 March 2016
53
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Churchill Serves as Sole Lead Arranger for a First Lien Credit Facility to Support Wynnchurch Capital’s Acquisition of Handgards
- Lowey Dannenberg Notifies Shoals Technologies Group, Inc. (“Shoals” or the “Company”) (NASDAQ: SHLS) Investors of Securities Class Action Lawsuit and Encourages Investors with more than $100,0
- Sdiptech AB (publ) publishes Annual Report and Sustainability Report for 2023
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!